NZ588649A - Quinuclidine compounds as alpha-7 nicotinic acetylcholine receptor ligands - Google Patents

Info

Publication number

NZ588649A

NZ588649A NZ588649A NZ58864909A NZ588649A NZ 588649 A NZ588649 A NZ 588649A NZ 588649 A NZ588649 A NZ 588649A NZ 58864909 A NZ58864909 A NZ 58864909A NZ 588649 A NZ588649 A NZ 588649A

Authority

NZ

New Zealand

Prior art keywords

mmol

nmr

pyrimidinyl

methyl

mhz

Prior art date

2008-04-23

Links

• Espacenet
• Global Dossier
• Discuss

• 239000003446 ligand Substances 0.000 title description 5
• 102000047725 alpha7 Nicotinic Acetylcholine Receptor Human genes 0.000 title description 2
• 108700006085 alpha7 Nicotinic Acetylcholine Receptor Proteins 0.000 title description 2
• 150000008584 quinuclidines Chemical class 0.000 title 1
• 150000001875 compounds Chemical class 0.000 claims abstract description 89
• 125000001424 substituent group Chemical group 0.000 claims abstract description 24
• 238000011282 treatment Methods 0.000 claims abstract description 12
• 208000024827 Alzheimer disease Diseases 0.000 claims abstract description 11
• 201000000980 schizophrenia Diseases 0.000 claims abstract description 11
• 239000003814 drug Substances 0.000 claims abstract description 8
• 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 4
• 125000002971 oxazolyl group Chemical group 0.000 claims abstract description 3
• 229910052739 hydrogen Inorganic materials 0.000 claims description 1147
• -1 2-indolonyl Chemical group 0.000 claims description 654
• 238000004895 liquid chromatography mass spectrometry Methods 0.000 claims description 394
• 239000007787 solid Substances 0.000 claims description 113
• OKKJLVBELUTLKV-VMNATFBRSA-N methanol-d1 Chemical compound [2H]OC OKKJLVBELUTLKV-VMNATFBRSA-N 0.000 claims description 51
• 150000003839 salts Chemical class 0.000 claims description 32
• DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical class OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 29
• 125000004076 pyridyl group Chemical group 0.000 claims description 27
• 229910052757 nitrogen Inorganic materials 0.000 claims description 20
• 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 19
• 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 19
• 125000000714 pyrimidinyl group Chemical group 0.000 claims description 17
• 125000000335 thiazolyl group Chemical group 0.000 claims description 13
• 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims description 10
• 125000001164 benzothiazolyl group Chemical group S1C(=NC2=C1C=CC=C2)* 0.000 claims description 10
• 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 10
• 125000002294 quinazolinyl group Chemical group N1=C(N=CC2=CC=CC=C12)* 0.000 claims description 10
• 125000001425 triazolyl group Chemical group 0.000 claims description 10
• 125000004093 cyano group Chemical group *C#N 0.000 claims description 9
• 125000003373 pyrazinyl group Chemical group 0.000 claims description 9
• 125000001624 naphthyl group Chemical group 0.000 claims description 8
• 125000001544 thienyl group Chemical group 0.000 claims description 8
• 125000006272 (C3-C7) cycloalkyl group Chemical group 0.000 claims description 7
• 125000003453 indazolyl group Chemical group N1N=C(C2=C1C=CC=C2)* 0.000 claims description 7
• 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 7
• 125000002098 pyridazinyl group Chemical group 0.000 claims description 7
• 125000000217 alkyl group Chemical group 0.000 claims description 6
• 125000006396 chloropyrazinyl group Chemical group 0.000 claims description 6
• 239000001257 hydrogen Substances 0.000 claims description 6
• 125000004541 benzoxazolyl group Chemical group O1C(=NC2=C1C=CC=C2)* 0.000 claims description 5
• 125000004612 furopyridinyl group Chemical group O1C(=CC2=C1C=CC=N2)* 0.000 claims description 5
• 125000002183 isoquinolinyl group Chemical group C1(=NC=CC2=CC=CC=C12)* 0.000 claims description 5
• 125000004593 naphthyridinyl group Chemical group N1=C(C=CC2=CC=CN=C12)* 0.000 claims description 5
• 125000002943 quinolinyl group Chemical group N1=C(C=CC2=CC=CC=C12)* 0.000 claims description 5
• 125000001567 quinoxalinyl group Chemical group N1=C(C=NC2=CC=CC=C12)* 0.000 claims description 5
• 239000003937 drug carrier Substances 0.000 claims description 4
• 125000004193 piperazinyl group Chemical group 0.000 claims description 4
• 125000003354 benzotriazolyl group Chemical group N1N=NC2=C1C=CC=C2* 0.000 claims description 3
• 125000006402 chloropyridazinyl group Chemical group 0.000 claims description 3
• 125000006390 chloropyrimidinyl group Chemical group 0.000 claims description 3
• 125000006399 methylpyrazinyl group Chemical group 0.000 claims description 3
• 125000006405 methylpyridazinyl group Chemical group 0.000 claims description 3
• 125000006393 methylpyrimidinyl group Chemical group 0.000 claims description 3
• ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 claims description 2
• 125000004603 benzisoxazolyl group Chemical group O1N=C(C2=C1C=CC=C2)* 0.000 claims description 2
• 125000002883 imidazolyl group Chemical group 0.000 claims description 2
• 125000001041 indolyl group Chemical group 0.000 claims description 2
• 125000000842 isoxazolyl group Chemical group 0.000 claims description 2
• 125000002757 morpholinyl group Chemical group 0.000 claims description 2
• 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
• 125000001715 oxadiazolyl group Chemical group 0.000 claims description 2
• 125000003386 piperidinyl group Chemical group 0.000 claims description 2
• 238000002360 preparation method Methods 0.000 claims description 2
• 125000003226 pyrazolyl group Chemical group 0.000 claims description 2
• 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 2
• 125000001113 thiadiazolyl group Chemical group 0.000 claims description 2
• 125000004306 triazinyl group Chemical group 0.000 claims description 2
• 125000001475 halogen functional group Chemical group 0.000 claims 8
• 125000003943 azolyl group Chemical group 0.000 claims 2
• 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 2
• 125000002393 azetidinyl group Chemical group 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 abstract description 3
• SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical class C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 abstract description 3
• USOMYWQXRPHQQC-SFHVURJKSA-N (3r)-n-(5-bromo-4-pyridin-3-ylpyrimidin-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound BrC1=CN=C(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)N=C1C1=CC=CN=C1 USOMYWQXRPHQQC-SFHVURJKSA-N 0.000 abstract 1
• WZQFQYUVIUGQRH-FQEVSTJZSA-N (3r)-n-[6-(3-methoxyphenyl)pyrimidin-4-yl]spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound COC1=CC=CC(C=2N=CN=C(NC=3O[C@@]4(C5CCN(CC5)C4)CN=3)C=2)=C1 WZQFQYUVIUGQRH-FQEVSTJZSA-N 0.000 abstract 1
• VEAWPMXEROMSKF-HNNXBMFYSA-N 2-[[(3r)-spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-yl]amino]-4h-[1,3]thiazolo[5,4-b]pyridin-5-one Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=NC(C=CC(N2)=O)=C2S1 VEAWPMXEROMSKF-HNNXBMFYSA-N 0.000 abstract 1
• XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 392
• 238000005481 NMR spectroscopy Methods 0.000 description 377
• OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 321
• ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 303
• TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 258
• 238000006243 chemical reaction Methods 0.000 description 223
• 239000000203 mixture Substances 0.000 description 209
• HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 168
• 235000019439 ethyl acetate Nutrition 0.000 description 133
• VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical class CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 133
• IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 128
• WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 120
• 239000000047 product Substances 0.000 description 114
• YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 106
• 239000000843 powder Substances 0.000 description 99
• HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 98
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 88
• HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 79
• 239000000243 solution Substances 0.000 description 75
• 150000002500 ions Chemical class 0.000 description 70
• CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 62
• 239000011541 reaction mixture Substances 0.000 description 60
• 238000010898 silica gel chromatography Methods 0.000 description 59
• 238000000034 method Methods 0.000 description 58
• BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 47
• CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 46
• 238000005160 1H NMR spectroscopy Methods 0.000 description 40
• VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 39
• 239000012043 crude product Substances 0.000 description 39
• QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 38
• 235000011114 ammonium hydroxide Nutrition 0.000 description 38
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 36
• QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 35
• RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 35
• ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 35
• 239000000725 suspension Substances 0.000 description 35
• WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 34
• 101150041968 CDC13 gene Proteins 0.000 description 33
• 239000002244 precipitate Substances 0.000 description 33
• IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 31
• 238000004587 chromatography analysis Methods 0.000 description 30
• 238000004440 column chromatography Methods 0.000 description 29
• OUKVGTYIZUXBIR-JZGIKJSDSA-N [(3s)-3-hydroxy-1-azoniabicyclo[2.2.2]octan-3-yl]methylazanium;dichloride Chemical compound Cl.Cl.C1CC2[C@@](CN)(O)CN1CC2 OUKVGTYIZUXBIR-JZGIKJSDSA-N 0.000 description 28
• PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 27
• 229910052938 sodium sulfate Inorganic materials 0.000 description 27
• 235000011152 sodium sulphate Nutrition 0.000 description 27
• 239000010410 layer Substances 0.000 description 26
• 229910000085 borane Inorganic materials 0.000 description 25
• 229910052943 magnesium sulfate Inorganic materials 0.000 description 25
• IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 24
• YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 24
• 239000003921 oil Substances 0.000 description 24
• 235000019198 oils Nutrition 0.000 description 24
• 239000012267 brine Substances 0.000 description 23
• OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 23
• 235000019341 magnesium sulphate Nutrition 0.000 description 23
• HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 23
• VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 22
• 239000013058 crude material Substances 0.000 description 22
• XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 21
• 229910000024 caesium carbonate Inorganic materials 0.000 description 21
• 238000000746 purification Methods 0.000 description 21
• 239000000908 ammonium hydroxide Substances 0.000 description 20
• 238000004809 thin layer chromatography Methods 0.000 description 20
• HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 19
• VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 19
• 238000003818 flash chromatography Methods 0.000 description 19
• 239000012071 phase Substances 0.000 description 19
• 238000003756 stirring Methods 0.000 description 19
• 239000012044 organic layer Substances 0.000 description 18
• 238000003556 assay Methods 0.000 description 17
• HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 17
• 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 17
• INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 17
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 16
• OKJPEAGHQZHRQV-UHFFFAOYSA-N Triiodomethane Natural products IC(I)I OKJPEAGHQZHRQV-UHFFFAOYSA-N 0.000 description 15
• 238000001914 filtration Methods 0.000 description 15
• 239000000741 silica gel Substances 0.000 description 15
• 229910002027 silica gel Inorganic materials 0.000 description 15
• CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
• HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical compound O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 description 14
• FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 13
• RAFNCPHFRHZCPS-UHFFFAOYSA-N di(imidazol-1-yl)methanethione Chemical compound C1=CN=CN1C(=S)N1C=CN=C1 RAFNCPHFRHZCPS-UHFFFAOYSA-N 0.000 description 13
• 230000003287 optical effect Effects 0.000 description 13
• 102000005962 receptors Human genes 0.000 description 13
• 108020003175 receptors Proteins 0.000 description 13
• 239000002904 solvent Substances 0.000 description 13
• YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 13
• UONKGCZCROZZCD-QMMMGPOBSA-N (3s)-3-(aminomethyl)-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CC2[C@@](CN)(O)CN1CC2 UONKGCZCROZZCD-QMMMGPOBSA-N 0.000 description 12
• QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 12
• 210000004027 cell Anatomy 0.000 description 12
• 239000000706 filtrate Substances 0.000 description 12
• UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 11
• 150000001412 amines Chemical class 0.000 description 11
• UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 10
• 238000012512 characterization method Methods 0.000 description 10
• 230000014759 maintenance of location Effects 0.000 description 10
• 239000007858 starting material Substances 0.000 description 10
• DUKKRSPKJMHASP-UHFFFAOYSA-N 6-chloropyrimidin-4-amine Chemical compound NC1=CC(Cl)=NC=N1 DUKKRSPKJMHASP-UHFFFAOYSA-N 0.000 description 9
• XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 9
• JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 9
• CAACGBPGDBJKFK-UHFFFAOYSA-N azanium;ethyl acetate;hydroxide Chemical compound [NH4+].[OH-].CCOC(C)=O CAACGBPGDBJKFK-UHFFFAOYSA-N 0.000 description 9
• 239000004202 carbamide Substances 0.000 description 9
• FIMJSWFMQJGVAM-UHFFFAOYSA-N chloroform;hydrate Chemical compound O.ClC(Cl)Cl FIMJSWFMQJGVAM-UHFFFAOYSA-N 0.000 description 9
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
• 239000000463 material Substances 0.000 description 9
• 239000011734 sodium Substances 0.000 description 9
• DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 description 8
• DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 8
• 102000019315 Nicotinic acetylcholine receptors Human genes 0.000 description 8
• 108050006807 Nicotinic acetylcholine receptors Proteins 0.000 description 8
• KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 8
• WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 8
• YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 8
• 239000003795 chemical substances by application Substances 0.000 description 8
• 125000005843 halogen group Chemical group 0.000 description 8
• 239000000543 intermediate Substances 0.000 description 8
• 229910052708 sodium Inorganic materials 0.000 description 8
• 229910000029 sodium carbonate Inorganic materials 0.000 description 8
• 238000012360 testing method Methods 0.000 description 8
• CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 7
• 108091006146 Channels Proteins 0.000 description 7
• 235000011089 carbon dioxide Nutrition 0.000 description 7
• 239000007788 liquid Substances 0.000 description 7
• 208000015122 neurodegenerative disease Diseases 0.000 description 7
• 208000024891 symptom Diseases 0.000 description 7
• ICSNLGPSRYBMBD-UHFFFAOYSA-N 2-aminopyridine Chemical compound NC1=CC=CC=N1 ICSNLGPSRYBMBD-UHFFFAOYSA-N 0.000 description 6
• 208000019022 Mood disease Diseases 0.000 description 6
• RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 6
• 239000008346 aqueous phase Substances 0.000 description 6
• 125000005605 benzo group Chemical group 0.000 description 6
• 239000003153 chemical reaction reagent Substances 0.000 description 6
• 230000000694 effects Effects 0.000 description 6
• 238000002953 preparative HPLC Methods 0.000 description 6
• 230000002829 reductive effect Effects 0.000 description 6
• 230000002441 reversible effect Effects 0.000 description 6
• UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 6
• ORIIXCOYEOIFSN-UHFFFAOYSA-N 1,3-benzothiazol-6-ol Chemical compound OC1=CC=C2N=CSC2=C1 ORIIXCOYEOIFSN-UHFFFAOYSA-N 0.000 description 5
• ADKICMRIVXDIOP-UHFFFAOYSA-N 4-isothiocyanato-6-methoxypyrimidine Chemical compound COC1=CC(N=C=S)=NC=N1 ADKICMRIVXDIOP-UHFFFAOYSA-N 0.000 description 5
• KRRTXVSBTPCDOS-UHFFFAOYSA-N 5-bromopyrazin-2-amine Chemical compound NC1=CN=C(Br)C=N1 KRRTXVSBTPCDOS-UHFFFAOYSA-N 0.000 description 5
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 5
• KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
• FKGQRXQOODICAT-UHFFFAOYSA-N di(imidazol-1-yl)methanimine Chemical compound C1=CN=CN1C(=N)N1C=CN=C1 FKGQRXQOODICAT-UHFFFAOYSA-N 0.000 description 5
• 201000010099 disease Diseases 0.000 description 5
• 150000002540 isothiocyanates Chemical class 0.000 description 5
• ZNNZYHKDIALBAK-UHFFFAOYSA-M potassium thiocyanate Chemical compound [K+].[S-]C#N ZNNZYHKDIALBAK-UHFFFAOYSA-M 0.000 description 5
• 238000010992 reflux Methods 0.000 description 5
• 238000004007 reversed phase HPLC Methods 0.000 description 5
• 229910000030 sodium bicarbonate Inorganic materials 0.000 description 5
• 235000017557 sodium bicarbonate Nutrition 0.000 description 5
• SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 description 4
• OUKVGTYIZUXBIR-UHFFFAOYSA-N (3-hydroxy-1-azoniabicyclo[2.2.2]octan-3-yl)methylazanium;dichloride Chemical compound Cl.Cl.C1CC2C(CN)(O)CN1CC2 OUKVGTYIZUXBIR-UHFFFAOYSA-N 0.000 description 4
• XJPZKYIHCLDXST-UHFFFAOYSA-N 4,6-dichloropyrimidine Chemical compound ClC1=CC(Cl)=NC=N1 XJPZKYIHCLDXST-UHFFFAOYSA-N 0.000 description 4
• VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 4
• VPRKGLYZWQCCHU-UHFFFAOYSA-N 6-pyridin-3-ylpyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=NC=CC=2)=N1 VPRKGLYZWQCCHU-UHFFFAOYSA-N 0.000 description 4
• NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
• WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 4
• WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 4
• LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 description 4
• PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 4
• 235000019502 Orange oil Nutrition 0.000 description 4
• 241000700159 Rattus Species 0.000 description 4
• OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 4
• 229960004373 acetylcholine Drugs 0.000 description 4
• 239000000556 agonist Substances 0.000 description 4
• GPRLTFBKWDERLU-UHFFFAOYSA-N bicyclo[2.2.2]octane Chemical compound C1CC2CCC1CC2 GPRLTFBKWDERLU-UHFFFAOYSA-N 0.000 description 4
• 230000027455 binding Effects 0.000 description 4
• GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
• 229910052794 bromium Inorganic materials 0.000 description 4
• 239000000872 buffer Substances 0.000 description 4
• 230000003185 calcium uptake Effects 0.000 description 4
• 230000006735 deficit Effects 0.000 description 4
• 208000035475 disorder Diseases 0.000 description 4
• 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
• 238000004128 high performance liquid chromatography Methods 0.000 description 4
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 4
• 229960002715 nicotine Drugs 0.000 description 4
• SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 description 4
• 239000010502 orange oil Substances 0.000 description 4
• HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 4
• BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
• 230000000750 progressive effect Effects 0.000 description 4
• 229920006395 saturated elastomer Polymers 0.000 description 4
• LENLQGBLVGGAMF-UHFFFAOYSA-N tributyl([1,2,4]triazolo[1,5-a]pyridin-6-yl)stannane Chemical compound C1=C([Sn](CCCC)(CCCC)CCCC)C=CC2=NC=NN21 LENLQGBLVGGAMF-UHFFFAOYSA-N 0.000 description 4
• KZGYCTBSZHPCAQ-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-n-([1,3]thiazolo[5,4-b]pyridin-2-yl)methanimine Chemical compound C1=CN=C2SC(N=C(SC)SC)=NC2=C1 KZGYCTBSZHPCAQ-UHFFFAOYSA-N 0.000 description 3
• WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 3
• RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
• QWENRTYMTSOGBR-UHFFFAOYSA-N 1H-1,2,3-Triazole Chemical compound C=1C=NNN=1 QWENRTYMTSOGBR-UHFFFAOYSA-N 0.000 description 3
• MFJBJIDWQXSZHR-UHFFFAOYSA-N 2,3-dichloro-6-isothiocyanatopyridine Chemical compound ClC1=CC=C(N=C=S)N=C1Cl MFJBJIDWQXSZHR-UHFFFAOYSA-N 0.000 description 3
• VSOBZMWGTWAHSR-UHFFFAOYSA-N 2-bromo-6-isothiocyanatopyridine Chemical compound BrC1=CC=CC(N=C=S)=N1 VSOBZMWGTWAHSR-UHFFFAOYSA-N 0.000 description 3
• WUACEPTXSRKMEX-UHFFFAOYSA-N 2-isothiocyanato-5-methylsulfanylpyrazine Chemical compound CSC1=CN=C(N=C=S)C=N1 WUACEPTXSRKMEX-UHFFFAOYSA-N 0.000 description 3
• DKHLVVSSFRDDKS-UHFFFAOYSA-N 3,5-dichloro-2-isothiocyanatopyridine Chemical compound ClC1=CN=C(N=C=S)C(Cl)=C1 DKHLVVSSFRDDKS-UHFFFAOYSA-N 0.000 description 3
• HPDLWLVRGCHZGT-UHFFFAOYSA-N 3-isothiocyanato-6-methylisoquinoline Chemical compound C1=NC(N=C=S)=CC2=CC(C)=CC=C21 HPDLWLVRGCHZGT-UHFFFAOYSA-N 0.000 description 3
• PFCDPPOYVKKKCP-UHFFFAOYSA-N 4,5-dichloro-2-isothiocyanatopyridine Chemical compound ClC1=CN=C(N=C=S)C=C1Cl PFCDPPOYVKKKCP-UHFFFAOYSA-N 0.000 description 3
• IELZPOFKHRZRGS-UHFFFAOYSA-N 4,5-dimethylpyrimidin-2-amine Chemical compound CC1=CN=C(N)N=C1C IELZPOFKHRZRGS-UHFFFAOYSA-N 0.000 description 3
• IUNZNINLPZAQDM-UHFFFAOYSA-N 4-(3-chlorophenyl)-6-isothiocyanatopyrimidine Chemical compound ClC1=CC=CC(C=2N=CN=C(N=C=S)C=2)=C1 IUNZNINLPZAQDM-UHFFFAOYSA-N 0.000 description 3
• YKDAOJYJASPGDM-UHFFFAOYSA-N 4-(4-chlorophenyl)-6-isothiocyanatopyrimidine Chemical compound C1=CC(Cl)=CC=C1C1=CC(N=C=S)=NC=N1 YKDAOJYJASPGDM-UHFFFAOYSA-N 0.000 description 3
• CJTDPEZNGURNJL-UHFFFAOYSA-N 4-chloro-6-(2,2,2-trifluoroethoxy)pyrimidine Chemical compound FC(F)(F)COC1=CC(Cl)=NC=N1 CJTDPEZNGURNJL-UHFFFAOYSA-N 0.000 description 3
• DQHCEDCSEAGFRM-UHFFFAOYSA-N 4-chloro-6-cyclopentyloxypyrimidine Chemical compound C1=NC(Cl)=CC(OC2CCCC2)=N1 DQHCEDCSEAGFRM-UHFFFAOYSA-N 0.000 description 3
• YYHYJXGSBDBGSF-UHFFFAOYSA-N 4-isothiocyanato-6-(3-methoxyphenyl)pyrimidine Chemical compound COC1=CC=CC(C=2N=CN=C(N=C=S)C=2)=C1 YYHYJXGSBDBGSF-UHFFFAOYSA-N 0.000 description 3
• ABIDGJQJJGUVID-UHFFFAOYSA-N 4-isothiocyanato-6-phenoxypyrimidine Chemical compound C1=NC(N=C=S)=CC(OC=2C=CC=CC=2)=N1 ABIDGJQJJGUVID-UHFFFAOYSA-N 0.000 description 3
• CNPURSDMOWDNOQ-UHFFFAOYSA-N 4-methoxy-7h-pyrrolo[2,3-d]pyrimidin-2-amine Chemical compound COC1=NC(N)=NC2=C1C=CN2 CNPURSDMOWDNOQ-UHFFFAOYSA-N 0.000 description 3
• AVRNZAITOUMSPB-UHFFFAOYSA-N 4-propan-2-ylpyrimidin-2-amine Chemical compound CC(C)C1=CC=NC(N)=N1 AVRNZAITOUMSPB-UHFFFAOYSA-N 0.000 description 3
• YTDSLQOPAQVPKD-UHFFFAOYSA-N 5,6-dichloroisoquinolin-3-amine Chemical compound ClC1=CC=C2C=NC(N)=CC2=C1Cl YTDSLQOPAQVPKD-UHFFFAOYSA-N 0.000 description 3
• LULBBYYBHKFKBH-UHFFFAOYSA-N 5,6-dichloropyridin-2-amine Chemical compound NC1=CC=C(Cl)C(Cl)=N1 LULBBYYBHKFKBH-UHFFFAOYSA-N 0.000 description 3
• ILDRNIDSVAZBMZ-UHFFFAOYSA-N 5-(trifluoromethyl)pyrazin-2-amine Chemical compound NC1=CN=C(C(F)(F)F)C=N1 ILDRNIDSVAZBMZ-UHFFFAOYSA-N 0.000 description 3
• UNAQXMQWXKKBEK-UHFFFAOYSA-N 5-chloro-2-isothiocyanato-4-methylpyridine Chemical compound CC1=CC(N=C=S)=NC=C1Cl UNAQXMQWXKKBEK-UHFFFAOYSA-N 0.000 description 3
• LLPVJZMTIYQTGU-UHFFFAOYSA-N 5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=N1 LLPVJZMTIYQTGU-UHFFFAOYSA-N 0.000 description 3
• KFKXUFHFJAKEKI-UHFFFAOYSA-N 5-methoxy-[1,3]thiazolo[5,4-d]pyrimidin-2-amine Chemical compound COC1=NC=C2N=C(N)SC2=N1 KFKXUFHFJAKEKI-UHFFFAOYSA-N 0.000 description 3
• BAXUDPKGRMMFBV-UHFFFAOYSA-N 5-phenylpyridin-3-amine Chemical compound NC1=CN=CC(C=2C=CC=CC=2)=C1 BAXUDPKGRMMFBV-UHFFFAOYSA-N 0.000 description 3
• XSYBQTMVQZSLGQ-UHFFFAOYSA-N 5-pyrrolidin-1-ylpyrazin-2-amine Chemical compound C1=NC(N)=CN=C1N1CCCC1 XSYBQTMVQZSLGQ-UHFFFAOYSA-N 0.000 description 3
• UAKAFAPSKXVOLF-UHFFFAOYSA-N 6,7-dichloro-3-isothiocyanatoisoquinoline Chemical compound N1=C(N=C=S)C=C2C=C(Cl)C(Cl)=CC2=C1 UAKAFAPSKXVOLF-UHFFFAOYSA-N 0.000 description 3
• ZYQBVXRVGUVSCW-UHFFFAOYSA-N 6-(3-chlorophenyl)pyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=C(Cl)C=CC=2)=N1 ZYQBVXRVGUVSCW-UHFFFAOYSA-N 0.000 description 3
• PUXOOQNLQPZQFB-UHFFFAOYSA-N 6-(difluoromethoxy)-1,3-benzothiazol-2-amine Chemical compound C1=C(OC(F)F)C=C2SC(N)=NC2=C1 PUXOOQNLQPZQFB-UHFFFAOYSA-N 0.000 description 3
• LZPYGFBASUNYEY-UHFFFAOYSA-N 6-(difluoromethoxy)pyridin-3-amine Chemical compound NC1=CC=C(OC(F)F)N=C1 LZPYGFBASUNYEY-UHFFFAOYSA-N 0.000 description 3
• TUWLYFAEAPMOJS-UHFFFAOYSA-N 6-(methoxymethyl)-1h-pyrimidin-4-one Chemical compound COCC1=CC(O)=NC=N1 TUWLYFAEAPMOJS-UHFFFAOYSA-N 0.000 description 3
• IKJPWKKDLNSXGW-UHFFFAOYSA-N 6-bromo-3-isothiocyanatoisoquinoline Chemical compound C1=NC(N=C=S)=CC2=CC(Br)=CC=C21 IKJPWKKDLNSXGW-UHFFFAOYSA-N 0.000 description 3
• BKLJUYPLUWUEOQ-UHFFFAOYSA-N 6-bromopyridin-2-amine Chemical compound NC1=CC=CC(Br)=N1 BKLJUYPLUWUEOQ-UHFFFAOYSA-N 0.000 description 3
• JKOGFRGFWFEFNT-UHFFFAOYSA-N 6-fluoro-1h-indazol-3-amine Chemical compound FC1=CC=C2C(N)=NNC2=C1 JKOGFRGFWFEFNT-UHFFFAOYSA-N 0.000 description 3
• QZPQDBMKUYEGQK-UHFFFAOYSA-N 6-fluoro-3-isothiocyanato-1h-indazole Chemical compound FC1=CC=C2C(N=C=S)=NNC2=C1 QZPQDBMKUYEGQK-UHFFFAOYSA-N 0.000 description 3
• YZSMZWMPCQWUOQ-UHFFFAOYSA-N 6-isothiocyanato-2,4-dimethylpyridine-3-carbonitrile Chemical compound CC1=CC(N=C=S)=NC(C)=C1C#N YZSMZWMPCQWUOQ-UHFFFAOYSA-N 0.000 description 3
• WTTQQWHDRLGJSP-UHFFFAOYSA-N 6-isothiocyanato-2-methylpyridine-3-carbonitrile Chemical compound CC1=NC(N=C=S)=CC=C1C#N WTTQQWHDRLGJSP-UHFFFAOYSA-N 0.000 description 3
• DBOBOPSSKJMSSY-UHFFFAOYSA-N 6-methylisoquinolin-3-amine Chemical compound C1=NC(N)=CC2=CC(C)=CC=C21 DBOBOPSSKJMSSY-UHFFFAOYSA-N 0.000 description 3
• NYXYYBHDSNBGOS-UHFFFAOYSA-N 6-phenylpyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=CC=CC=2)=N1 NYXYYBHDSNBGOS-UHFFFAOYSA-N 0.000 description 3
• LEGHXWSIXMQCGW-UHFFFAOYSA-N 6-pyridin-4-ylpyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=CN=CC=2)=N1 LEGHXWSIXMQCGW-UHFFFAOYSA-N 0.000 description 3
• GVERQUMLAYWTMA-UHFFFAOYSA-N 7-methoxy-1h-quinoxalin-2-one Chemical compound N1=CC(O)=NC2=CC(OC)=CC=C21 GVERQUMLAYWTMA-UHFFFAOYSA-N 0.000 description 3
• UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
• 241001136616 Methone Species 0.000 description 3
• QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
• NCZQAIFOXJOCFI-UHFFFAOYSA-N [1,2,4]triazolo[4,3-a]pyridin-3-amine Chemical compound C1=CC=CN2C(N)=NN=C21 NCZQAIFOXJOCFI-UHFFFAOYSA-N 0.000 description 3
• 239000002253 acid Substances 0.000 description 3
• 230000004913 activation Effects 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 230000015572 biosynthetic process Effects 0.000 description 3
• 210000004556 brain Anatomy 0.000 description 3
• 229940045348 brown mixture Drugs 0.000 description 3
• 210000003169 central nervous system Anatomy 0.000 description 3
• 230000003920 cognitive function Effects 0.000 description 3
• BADXJIPKFRBFOT-UHFFFAOYSA-N dimedone Chemical compound CC1(C)CC(=O)CC(=O)C1 BADXJIPKFRBFOT-UHFFFAOYSA-N 0.000 description 3
• 229940079593 drug Drugs 0.000 description 3
• XFSYPTPQPTXLEF-UHFFFAOYSA-N ethyl n-carbamothioylcarbamate;5-methoxypyridin-2-amine Chemical compound CCOC(=O)NC(N)=S.COC1=CC=C(N)N=C1 XFSYPTPQPTXLEF-UHFFFAOYSA-N 0.000 description 3
• 239000012065 filter cake Substances 0.000 description 3
• 230000006870 function Effects 0.000 description 3
• IWMQAUYDCYPLFK-UHFFFAOYSA-N furo[3,2-c]pyridin-4-amine Chemical compound NC1=NC=CC2=C1C=CO2 IWMQAUYDCYPLFK-UHFFFAOYSA-N 0.000 description 3
• 150000002431 hydrogen Chemical class 0.000 description 3
• XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
• 239000005457 ice water Substances 0.000 description 3
• 230000003834 intracellular effect Effects 0.000 description 3
• 238000011068 loading method Methods 0.000 description 3
• 238000004949 mass spectrometry Methods 0.000 description 3
• 238000005259 measurement Methods 0.000 description 3
• 239000012528 membrane Substances 0.000 description 3
• 230000015654 memory Effects 0.000 description 3
• CKJNUZNMWOVDFN-UHFFFAOYSA-N methanone Chemical compound O=[CH-] CKJNUZNMWOVDFN-UHFFFAOYSA-N 0.000 description 3
• YKOUABZEDZDJEY-UHFFFAOYSA-N methyl 2,2-diethoxyethanimidate Chemical compound CCOC(OCC)C(=N)OC YKOUABZEDZDJEY-UHFFFAOYSA-N 0.000 description 3
• PSQGPXUZFGQICZ-UHFFFAOYSA-N n'-[(2,4-dichlorophenyl)methyl]-2,2-diethoxyethanimidamide Chemical compound CCOC(OCC)C(=N)NCC1=CC=C(Cl)C=C1Cl PSQGPXUZFGQICZ-UHFFFAOYSA-N 0.000 description 3
• XMJSRIGSOQCHNI-UHFFFAOYSA-N n-(1,3-thiazol-2-yl)imidazole-1-carbothioamide Chemical compound C1=CN=CN1C(=S)NC1=NC=CS1 XMJSRIGSOQCHNI-UHFFFAOYSA-N 0.000 description 3
• KYEKKLZQGRIPLQ-UHFFFAOYSA-N n-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C=2CCCCC=2SC=1NC(=S)N1C=CN=C1 KYEKKLZQGRIPLQ-UHFFFAOYSA-N 0.000 description 3
• MTIALXJECNTTKZ-UHFFFAOYSA-N n-(5,6-dichloropyridin-2-yl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC=C(Cl)C(Cl)=N1 MTIALXJECNTTKZ-UHFFFAOYSA-N 0.000 description 3
• CKYGNDBIVBKWDQ-UHFFFAOYSA-N n-(5-chloro-1,3-benzoxazol-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound ClC1=CC=C2OC(N=C(SC)SC)=NC2=C1 CKYGNDBIVBKWDQ-UHFFFAOYSA-N 0.000 description 3
• DUZMBBAWLGCEQE-UHFFFAOYSA-N n-(6-chloropyrimidin-4-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound CSC(SC)=NC1=CC(Cl)=NC=N1 DUZMBBAWLGCEQE-UHFFFAOYSA-N 0.000 description 3
• IWZSFFYAXNHSIT-UHFFFAOYSA-N n-(7-methoxy-5-methyl-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound COC1=NC(C)=NC2=C1N=C(N=C(SC)SC)S2 IWZSFFYAXNHSIT-UHFFFAOYSA-N 0.000 description 3
• KYMBMYMZVKUDDV-UHFFFAOYSA-N n-[6-[tert-butyl(dimethyl)silyl]oxy-1,3-benzothiazol-2-yl]imidazole-1-carbothioamide Chemical compound S1C2=CC(O[Si](C)(C)C(C)(C)C)=CC=C2N=C1NC(=S)N1C=CN=C1 KYMBMYMZVKUDDV-UHFFFAOYSA-N 0.000 description 3
• 239000012074 organic phase Substances 0.000 description 3
• 239000000137 peptide hydrolase inhibitor Substances 0.000 description 3
• XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 3
• 229940116357 potassium thiocyanate Drugs 0.000 description 3
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
• 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 description 3
• 230000000698 schizophrenic effect Effects 0.000 description 3
• 239000000126 substance Substances 0.000 description 3
• VJBULGFITURQHJ-UHFFFAOYSA-N tert-butyl n-[6-(pyrrolidine-1-carbonyl)-1,3-benzothiazol-2-yl]carbamate Chemical compound C1=C2SC(NC(=O)OC(C)(C)C)=NC2=CC=C1C(=O)N1CCCC1 VJBULGFITURQHJ-UHFFFAOYSA-N 0.000 description 3
• 238000002560 therapeutic procedure Methods 0.000 description 3
• 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 3
• LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
• QOWBXWFYRXSBAS-UHFFFAOYSA-N (2,4-dimethoxyphenyl)methanamine Chemical compound COC1=CC=C(CN)C(OC)=C1 QOWBXWFYRXSBAS-UHFFFAOYSA-N 0.000 description 2
• NHLSXQSQHXPPDQ-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-n-(5-phenylmethoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)methanimine Chemical compound N1=C2SC(N=C(SC)SC)=NC2=CC=C1OCC1=CC=CC=C1 NHLSXQSQHXPPDQ-UHFFFAOYSA-N 0.000 description 2
• JPBLHOJFMBOCAF-UHFFFAOYSA-N 1,3-benzoxazol-2-amine Chemical compound C1=CC=C2OC(N)=NC2=C1 JPBLHOJFMBOCAF-UHFFFAOYSA-N 0.000 description 2
• KXMMNJQMGILZDB-UHFFFAOYSA-N 1-(2-oxopyridine-1-carbothioyl)pyridin-2-one Chemical compound O=C1C=CC=CN1C(=S)N1C(=O)C=CC=C1 KXMMNJQMGILZDB-UHFFFAOYSA-N 0.000 description 2
• WLHADOSXRICWAB-UHFFFAOYSA-N 2-(difluoromethoxy)-5-nitropyridine Chemical compound [O-][N+](=O)C1=CC=C(OC(F)F)N=C1 WLHADOSXRICWAB-UHFFFAOYSA-N 0.000 description 2
• CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 2
• WTSWSBPEZJCSMC-UHFFFAOYSA-N 2-chloro-5-(difluoromethoxy)pyrimidine Chemical compound FC(F)OC1=CN=C(Cl)N=C1 WTSWSBPEZJCSMC-UHFFFAOYSA-N 0.000 description 2
• MANHSBQXHPLZSR-UHFFFAOYSA-N 2-chloro-5-cyclopentyloxypyrimidine Chemical compound C1=NC(Cl)=NC=C1OC1CCCC1 MANHSBQXHPLZSR-UHFFFAOYSA-N 0.000 description 2
• SXUWYCHACCYVMS-UHFFFAOYSA-N 2-chloro-6-methoxyquinoxaline Chemical compound N1=C(Cl)C=NC2=CC(OC)=CC=C21 SXUWYCHACCYVMS-UHFFFAOYSA-N 0.000 description 2
• BOGPIHXNWPTGNH-UHFFFAOYSA-N 2-chloropyrimidin-5-ol Chemical compound OC1=CN=C(Cl)N=C1 BOGPIHXNWPTGNH-UHFFFAOYSA-N 0.000 description 2
• UBKKNWJGYLSDSJ-UHFFFAOYSA-N 2-methylpyridine-3-carbonitrile Chemical compound CC1=NC=CC=C1C#N UBKKNWJGYLSDSJ-UHFFFAOYSA-N 0.000 description 2
• CUYKNJBYIJFRCU-UHFFFAOYSA-N 3-aminopyridine Chemical compound NC1=CC=CN=C1 CUYKNJBYIJFRCU-UHFFFAOYSA-N 0.000 description 2
• UGMQFWDSELPKKP-UHFFFAOYSA-N 3-isothiocyanatoisoquinoline Chemical compound C1=CC=C2C=NC(N=C=S)=CC2=C1 UGMQFWDSELPKKP-UHFFFAOYSA-N 0.000 description 2
• QOOQUMTZWQEHTR-UHFFFAOYSA-N 4-chloro-6-(methoxymethyl)pyrimidine Chemical compound COCC1=CC(Cl)=NC=N1 QOOQUMTZWQEHTR-UHFFFAOYSA-N 0.000 description 2
• MFDBYMJQLWCZKY-UHFFFAOYSA-N 4-isothiocyanato-6-(2-methoxypyrimidin-5-yl)pyrimidine Chemical compound C1=NC(OC)=NC=C1C1=CC(N=C=S)=NC=N1 MFDBYMJQLWCZKY-UHFFFAOYSA-N 0.000 description 2
• OGBVYBGVSBZBLT-UHFFFAOYSA-N 4-isothiocyanato-6-pyridin-3-ylpyrimidine Chemical compound C1=NC(N=C=S)=CC(C=2C=NC=CC=2)=N1 OGBVYBGVSBZBLT-UHFFFAOYSA-N 0.000 description 2
• CIIVQXITBPFBAK-UHFFFAOYSA-N 4-isothiocyanato-6-pyridin-4-ylpyrimidine Chemical compound C1=NC(N=C=S)=CC(C=2C=CN=CC=2)=N1 CIIVQXITBPFBAK-UHFFFAOYSA-N 0.000 description 2
• IKECPQGVQXXBSD-UHFFFAOYSA-N 5,6-dichloro-3-isothiocyanatoisoquinoline Chemical compound C1=NC(N=C=S)=CC2=C(Cl)C(Cl)=CC=C21 IKECPQGVQXXBSD-UHFFFAOYSA-N 0.000 description 2
• IPBKLPYWVRTALX-UHFFFAOYSA-N 5-methylsulfanylpyrazin-2-amine Chemical compound CSC1=CN=C(N)C=N1 IPBKLPYWVRTALX-UHFFFAOYSA-N 0.000 description 2
• VZKIMVYWEBBKGS-UHFFFAOYSA-N 5-phenylmethoxy-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound N1=C2SC(N)=NC2=CC=C1OCC1=CC=CC=C1 VZKIMVYWEBBKGS-UHFFFAOYSA-N 0.000 description 2
• SJGNIZFAJDLNQE-UHFFFAOYSA-N 5-pyridin-3-ylpyrazin-2-amine Chemical compound C1=NC(N)=CN=C1C1=CC=CN=C1 SJGNIZFAJDLNQE-UHFFFAOYSA-N 0.000 description 2
• SVFTZRIJBQMZKB-UHFFFAOYSA-N 6,7-dichloroisoquinolin-3-amine Chemical compound ClC1=C(Cl)C=C2C=NC(N)=CC2=C1 SVFTZRIJBQMZKB-UHFFFAOYSA-N 0.000 description 2
• KQJHSCZATVSGTO-UHFFFAOYSA-N 6-(2,2,2-trifluoroethoxy)pyrimidin-4-amine Chemical compound NC1=CC(OCC(F)(F)F)=NC=N1 KQJHSCZATVSGTO-UHFFFAOYSA-N 0.000 description 2
• TUABPDBZFQJDHM-UHFFFAOYSA-N 6-(3-methoxyphenyl)pyrimidin-4-amine Chemical compound COC1=CC=CC(C=2N=CN=C(N)C=2)=C1 TUABPDBZFQJDHM-UHFFFAOYSA-N 0.000 description 2
• LHRMIXPETPBOOD-UHFFFAOYSA-N 6-(difluoromethoxy)-1-methylindazol-3-amine Chemical compound C1=C(OC(F)F)C=C2N(C)N=C(N)C2=C1 LHRMIXPETPBOOD-UHFFFAOYSA-N 0.000 description 2
• ZEEJRACEEDQANN-UHFFFAOYSA-N 6-(methoxymethyl)pyrimidin-4-amine Chemical compound COCC1=CC(N)=NC=N1 ZEEJRACEEDQANN-UHFFFAOYSA-N 0.000 description 2
• SYEUUDPGKMMKRU-UHFFFAOYSA-N 6-methoxy-1h-quinoxalin-2-one Chemical compound N1C(=O)C=NC2=CC(OC)=CC=C21 SYEUUDPGKMMKRU-UHFFFAOYSA-N 0.000 description 2
• YUGIDNINXCKSJH-UHFFFAOYSA-N 6-methoxyquinoxalin-2-amine Chemical compound N1=C(N)C=NC2=CC(OC)=CC=C21 YUGIDNINXCKSJH-UHFFFAOYSA-N 0.000 description 2
• VZXLYMCMLMJTEI-UHFFFAOYSA-N 6-phenoxypyrimidin-4-amine Chemical compound C1=NC(N)=CC(OC=2C=CC=CC=2)=N1 VZXLYMCMLMJTEI-UHFFFAOYSA-N 0.000 description 2
• QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
• XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
• BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
• 101100273797 Caenorhabditis elegans pct-1 gene Proteins 0.000 description 2
• UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
• 101150049660 DRD2 gene Proteins 0.000 description 2
• BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
• OUVXYXNWSVIOSJ-UHFFFAOYSA-N Fluo-4 Chemical compound CC1=CC=C(N(CC(O)=O)CC(O)=O)C(OCCOC=2C(=CC=C(C=2)C2=C3C=C(F)C(=O)C=C3OC3=CC(O)=C(F)C=C32)N(CC(O)=O)CC(O)=O)=C1 OUVXYXNWSVIOSJ-UHFFFAOYSA-N 0.000 description 2
• SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
• 102000004310 Ion Channels Human genes 0.000 description 2
• 108090000862 Ion Channels Proteins 0.000 description 2
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
• JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
• 208000028017 Psychotic disease Diseases 0.000 description 2
• KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
• JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 2
• SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
• KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
• 239000007983 Tris buffer Substances 0.000 description 2
• AVSYPWBWFBPSEU-UHFFFAOYSA-N [1,3]oxazolo[4,5-b]pyridin-2-amine Chemical compound C1=CC=C2OC(N)=NC2=N1 AVSYPWBWFBPSEU-UHFFFAOYSA-N 0.000 description 2
• OGWPHTRWLWDCOC-UHFFFAOYSA-N [1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound C1=CN=C2SC(N)=NC2=C1 OGWPHTRWLWDCOC-UHFFFAOYSA-N 0.000 description 2
• 102000015296 acetylcholine-gated cation-selective channel activity proteins Human genes 0.000 description 2
• 108040006409 acetylcholine-gated cation-selective channel activity proteins Proteins 0.000 description 2
• 235000019270 ammonium chloride Nutrition 0.000 description 2
• 238000004458 analytical method Methods 0.000 description 2
• 239000000164 antipsychotic agent Substances 0.000 description 2
• IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
• HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 2
• UORVGPXVDQYIDP-BJUDXGSMSA-N borane Chemical group [10BH3] UORVGPXVDQYIDP-BJUDXGSMSA-N 0.000 description 2
• 230000005587 bubbling Effects 0.000 description 2
• 239000001110 calcium chloride Substances 0.000 description 2
• 229910001628 calcium chloride Inorganic materials 0.000 description 2
• 235000011148 calcium chloride Nutrition 0.000 description 2
• 150000001718 carbodiimides Chemical class 0.000 description 2
• 229910052799 carbon Inorganic materials 0.000 description 2
• 208000010877 cognitive disease Diseases 0.000 description 2
• 230000001149 cognitive effect Effects 0.000 description 2
• 239000013078 crystal Substances 0.000 description 2
• 125000000753 cycloalkyl group Chemical group 0.000 description 2
• 238000007405 data analysis Methods 0.000 description 2
• BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 2
• 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 2
• VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
• 238000003821 enantio-separation Methods 0.000 description 2
• 230000007613 environmental effect Effects 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 239000000284 extract Substances 0.000 description 2
• 230000002068 genetic effect Effects 0.000 description 2
• 229910052736 halogen Inorganic materials 0.000 description 2
• 150000002367 halogens Chemical class 0.000 description 2
• 125000005241 heteroarylamino group Chemical group 0.000 description 2
• 210000001320 hippocampus Anatomy 0.000 description 2
• IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine hydrate Chemical compound O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 description 2
• 150000002430 hydrocarbons Chemical group 0.000 description 2
• 150000003840 hydrochlorides Chemical class 0.000 description 2
• XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
• NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 2
• 239000012535 impurity Substances 0.000 description 2
• AWJUIBRHMBBTKR-UHFFFAOYSA-N isoquinoline Chemical compound C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 description 2
• 150000002576 ketones Chemical class 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 239000011777 magnesium Substances 0.000 description 2
• 229910052749 magnesium Inorganic materials 0.000 description 2
• RPGSTSWVRNPAKP-UHFFFAOYSA-N n-(1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C2=CC=CC=C2SC=1NC(=S)N1C=CN=C1 RPGSTSWVRNPAKP-UHFFFAOYSA-N 0.000 description 2
• PEVWFQQFUKFJFK-UHFFFAOYSA-N n-(1,3-benzoxazol-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound C1=CC=C2OC(N=C(SC)SC)=NC2=C1 PEVWFQQFUKFJFK-UHFFFAOYSA-N 0.000 description 2
• LPCWBIDEYNTTTN-UHFFFAOYSA-N n-(4-propan-2-yl-1,3-thiazol-2-yl)imidazole-1-carbothioamide Chemical compound CC(C)C1=CSC(NC(=S)N2C=NC=C2)=N1 LPCWBIDEYNTTTN-UHFFFAOYSA-N 0.000 description 2
• BIRKZPAWNVZXGA-UHFFFAOYSA-N n-(5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound C1=C(Cl)N=C2SC(N=C(SC)SC)=NC2=C1 BIRKZPAWNVZXGA-UHFFFAOYSA-N 0.000 description 2
• HJELGMRULNTAPD-UHFFFAOYSA-N n-(5-methoxy-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound COC1=NC=C2N=C(N=C(SC)SC)SC2=N1 HJELGMRULNTAPD-UHFFFAOYSA-N 0.000 description 2
• LRAMDZDYWGJMGU-UHFFFAOYSA-N n-[2-(imidazole-1-carbothioylamino)-1,3-benzothiazol-6-yl]acetamide Chemical compound S1C2=CC(NC(=O)C)=CC=C2N=C1NC(=S)N1C=CN=C1 LRAMDZDYWGJMGU-UHFFFAOYSA-N 0.000 description 2
• LZNSBKRVTSLHIE-UHFFFAOYSA-N n-[5-(4-methoxyphenyl)-1,3-thiazol-2-yl]imidazole-1-carbothioamide Chemical compound C1=CC(OC)=CC=C1C(S1)=CN=C1NC(=S)N1C=NC=C1 LZNSBKRVTSLHIE-UHFFFAOYSA-N 0.000 description 2
• XXIXRNVGOZQCDX-UHFFFAOYSA-N n-[5-(difluoromethoxy)-[1,3]thiazolo[5,4-b]pyridin-2-yl]imidazole-1-carbothioamide Chemical compound S1C2=NC(OC(F)F)=CC=C2N=C1NC(=S)N1C=CN=C1 XXIXRNVGOZQCDX-UHFFFAOYSA-N 0.000 description 2
• YBDKBVGKMUKXGV-UHFFFAOYSA-N n-[6-(difluoromethoxy)-1,3-benzothiazol-2-yl]imidazole-1-carbothioamide Chemical compound S1C2=CC(OC(F)F)=CC=C2N=C1NC(=S)N1C=CN=C1 YBDKBVGKMUKXGV-UHFFFAOYSA-N 0.000 description 2
• 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
• 239000008188 pellet Substances 0.000 description 2
• 239000000546 pharmaceutical excipient Substances 0.000 description 2
• 230000000144 pharmacologic effect Effects 0.000 description 2
• 229910000027 potassium carbonate Inorganic materials 0.000 description 2
• 230000036515 potency Effects 0.000 description 2
• XFTQRUTUGRCSGO-UHFFFAOYSA-N pyrazin-2-amine Chemical compound NC1=CN=CC=N1 XFTQRUTUGRCSGO-UHFFFAOYSA-N 0.000 description 2
• 238000011002 quantification Methods 0.000 description 2
• XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
• 230000009467 reduction Effects 0.000 description 2
• 230000004044 response Effects 0.000 description 2
• 238000012552 review Methods 0.000 description 2
• 239000000779 smoke Substances 0.000 description 2
• WRIKHQLVHPKCJU-UHFFFAOYSA-N sodium bis(trimethylsilyl)amide Chemical compound C[Si](C)(C)N([Na])[Si](C)(C)C WRIKHQLVHPKCJU-UHFFFAOYSA-N 0.000 description 2
• 239000012312 sodium hydride Substances 0.000 description 2
• 229910000104 sodium hydride Inorganic materials 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 150000003585 thioureas Chemical class 0.000 description 2
• VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
• PYOKUURKVVELLB-UHFFFAOYSA-N trimethyl orthoformate Chemical compound COC(OC)OC PYOKUURKVVELLB-UHFFFAOYSA-N 0.000 description 2
• 239000003981 vehicle Substances 0.000 description 2
• SJUKJZSTBBSGHF-UHFFFAOYSA-N (2,4-dichlorophenyl)methanamine Chemical compound NCC1=CC=C(Cl)C=C1Cl SJUKJZSTBBSGHF-UHFFFAOYSA-N 0.000 description 1
• YPWAJLGHACDYQS-UHFFFAOYSA-N (2-methoxypyrimidin-5-yl)boronic acid Chemical compound COC1=NC=C(B(O)O)C=N1 YPWAJLGHACDYQS-UHFFFAOYSA-N 0.000 description 1
• DOMQFIFVDIAOOT-ROUUACIJSA-N (2S,3R)-N-[4-(2,6-dimethoxyphenyl)-5-(5-methylpyridin-3-yl)-1,2,4-triazol-3-yl]-3-(5-methylpyrimidin-2-yl)butane-2-sulfonamide Chemical compound COC1=C(C(=CC=C1)OC)N1C(=NN=C1C=1C=NC=C(C=1)C)NS(=O)(=O)[C@@H](C)[C@H](C)C1=NC=C(C=N1)C DOMQFIFVDIAOOT-ROUUACIJSA-N 0.000 description 1
• BSVHTRRLCAVQCZ-JDEXMCKMSA-N (2s)-1-[(2s)-1-[(2s)-1-[(2s)-1-[(2s)-1-[(2s)-1-[(2s)-2-[[(2s)-1-[(2s)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]-3-carboxypropanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrrolidine-2-carbonyl]pyrro Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=C(O)C=C1 BSVHTRRLCAVQCZ-JDEXMCKMSA-N 0.000 description 1
• UGEQUCUBWNAUJS-UHFFFAOYSA-N (3-bromophenyl)methanamine;hydrochloride Chemical compound Cl.NCC1=CC=CC(Br)=C1 UGEQUCUBWNAUJS-UHFFFAOYSA-N 0.000 description 1
• SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 1
• NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 1
• KEEAZYDQOLFVOL-CQSZACIVSA-N (3S)-N-pyridin-3-ylspiro[1-azabicyclo[2.2.2]octane-3,5'-4H-1,3-oxazole]-2'-amine Chemical compound N12C[C@@]3(C(CC1)CC2)CN/C(/O3)=N\C=1C=NC=CC=1 KEEAZYDQOLFVOL-CQSZACIVSA-N 0.000 description 1
• GTWJGHJRSNOFFG-FQEVSTJZSA-N (3r)-n-(6,8-dimethylisoquinolin-3-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2[C@]1(O1)CN=C1NC1=CC2=CC(C)=CC(C)=C2C=N1 GTWJGHJRSNOFFG-FQEVSTJZSA-N 0.000 description 1
• AMXYESZREAWKMZ-AWEZNQCLSA-N (3r)-n-(6-methylsulfanylpyrimidin-4-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1=NC(SC)=CC(NC=2O[C@@]3(C4CCN(CC4)C3)CN=2)=N1 AMXYESZREAWKMZ-AWEZNQCLSA-N 0.000 description 1
• BVYUYDBWQMSOKM-UHFFFAOYSA-N (4-bromophenyl)methanamine;hydron;chloride Chemical compound Cl.NCC1=CC=C(Br)C=C1 BVYUYDBWQMSOKM-UHFFFAOYSA-N 0.000 description 1
• CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
• HMTSWYPNXFHGEP-UHFFFAOYSA-N (4-methylphenyl)methanamine Chemical compound CC1=CC=C(CN)C=C1 HMTSWYPNXFHGEP-UHFFFAOYSA-N 0.000 description 1
• UKGJZDSUJSPAJL-YPUOHESYSA-N (e)-n-[(1r)-1-[3,5-difluoro-4-(methanesulfonamido)phenyl]ethyl]-3-[2-propyl-6-(trifluoromethyl)pyridin-3-yl]prop-2-enamide Chemical compound CCCC1=NC(C(F)(F)F)=CC=C1\C=C\C(=O)N[C@H](C)C1=CC(F)=C(NS(C)(=O)=O)C(F)=C1 UKGJZDSUJSPAJL-YPUOHESYSA-N 0.000 description 1
• FHUDAMLDXFJHJE-UHFFFAOYSA-N 1,1,1-trifluoropropan-2-one Chemical compound CC(=O)C(F)(F)F FHUDAMLDXFJHJE-UHFFFAOYSA-N 0.000 description 1
• IXZYSKNWHPRGKV-UHFFFAOYSA-N 1,1-bis(methylsulfanyl)-n-([1,3]oxazolo[4,5-b]pyridin-2-yl)methanimine Chemical compound C1=CC=C2OC(N=C(SC)SC)=NC2=N1 IXZYSKNWHPRGKV-UHFFFAOYSA-N 0.000 description 1
• CSNIZNHTOVFARY-UHFFFAOYSA-N 1,2-benzothiazole Chemical compound C1=CC=C2C=NSC2=C1 CSNIZNHTOVFARY-UHFFFAOYSA-N 0.000 description 1
• KTZQTRPPVKQPFO-UHFFFAOYSA-N 1,2-benzoxazole Chemical compound C1=CC=C2C=NOC2=C1 KTZQTRPPVKQPFO-UHFFFAOYSA-N 0.000 description 1
• DMPZJACLHDWUFS-UHFFFAOYSA-N 1,3-benzothiazole-6-carboxylic acid Chemical compound OC(=O)C1=CC=C2N=CSC2=C1 DMPZJACLHDWUFS-UHFFFAOYSA-N 0.000 description 1
• BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical compound C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
• ACTKAGSPIFDCMF-UHFFFAOYSA-N 1,3-oxazol-2-amine Chemical compound NC1=NC=CO1 ACTKAGSPIFDCMF-UHFFFAOYSA-N 0.000 description 1
• RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
• ACJRDZFAGYZZNF-IBGZPJMESA-N 1-[[(3s)-3-hydroxy-1-azabicyclo[2.2.2]octan-3-yl]methyl]-3-(6-methylisoquinolin-3-yl)thiourea Chemical compound C1N(CC2)CCC2[C@]1(O)CNC(=S)NC1=CC2=CC(C)=CC=C2C=N1 ACJRDZFAGYZZNF-IBGZPJMESA-N 0.000 description 1
• ZKMZPXWMMSBLNO-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octan-3-one Chemical compound C1CC2C(=O)CN1CC2 ZKMZPXWMMSBLNO-UHFFFAOYSA-N 0.000 description 1
• MNBAABZKRCNMAP-UHFFFAOYSA-N 1-azabicyclo[2.2.2]octane;4,5-dihydro-1,3-oxazole Chemical class C1CN=CO1.C1CC2CCN1CC2 MNBAABZKRCNMAP-UHFFFAOYSA-N 0.000 description 1
• PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
• DWEJKMCALRBDMV-UHFFFAOYSA-N 1-methoxyquinoxalin-2-one Chemical compound CON1C(C=NC2=CC=CC=C12)=O DWEJKMCALRBDMV-UHFFFAOYSA-N 0.000 description 1
• NYLGITXFVVEBLZ-UHFFFAOYSA-N 1-methylindazol-3-amine Chemical compound C1=CC=C2N(C)N=C(N)C2=C1 NYLGITXFVVEBLZ-UHFFFAOYSA-N 0.000 description 1
• 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
• HYZJCKYKOHLVJF-UHFFFAOYSA-N 1H-benzimidazole Chemical compound C1=CC=C2NC=NC2=C1 HYZJCKYKOHLVJF-UHFFFAOYSA-N 0.000 description 1
• BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 description 1
• DSKGWFQMJHBHRT-UHFFFAOYSA-N 2,2-diethoxyacetamide Chemical compound CCOC(C(N)=O)OCC DSKGWFQMJHBHRT-UHFFFAOYSA-N 0.000 description 1
• ALUQMCBDQKDRAK-UHFFFAOYSA-N 2,3,3a,4-tetrahydro-1,3-benzothiazole Chemical compound C1C=CC=C2SCNC21 ALUQMCBDQKDRAK-UHFFFAOYSA-N 0.000 description 1
• LJFDXXUKKMEQKE-UHFFFAOYSA-N 2,4-difluorobenzonitrile Chemical compound FC1=CC=C(C#N)C(F)=C1 LJFDXXUKKMEQKE-UHFFFAOYSA-N 0.000 description 1
• FFRJGTXQBXNARN-UHFFFAOYSA-N 2-(aminomethyl)-1-azabicyclo[2.2.2]octan-3-ol Chemical compound C1CN2C(CN)C(O)C1CC2 FFRJGTXQBXNARN-UHFFFAOYSA-N 0.000 description 1
• QBIDHEZNYLHWBR-UHFFFAOYSA-N 2-(methoxymethyl)pyrimidine Chemical compound COCC1=NC=CC=N1 QBIDHEZNYLHWBR-UHFFFAOYSA-N 0.000 description 1
• IMSODMZESSGVBE-UHFFFAOYSA-N 2-Oxazoline Chemical compound C1CN=CO1 IMSODMZESSGVBE-UHFFFAOYSA-N 0.000 description 1
• JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
• UHGULLIUJBCTEF-UHFFFAOYSA-N 2-aminobenzothiazole Chemical compound C1=CC=C2SC(N)=NC2=C1 UHGULLIUJBCTEF-UHFFFAOYSA-N 0.000 description 1
• BMTSZVZQNMNPCT-UHFFFAOYSA-N 2-aminopyridin-3-ol Chemical compound NC1=NC=CC=C1O BMTSZVZQNMNPCT-UHFFFAOYSA-N 0.000 description 1
• GNTGEMWEXKBWBX-UHFFFAOYSA-N 2-bromopyridin-4-amine Chemical compound NC1=CC=NC(Br)=C1 GNTGEMWEXKBWBX-UHFFFAOYSA-N 0.000 description 1
• AOZNIFQUCUSYLD-UHFFFAOYSA-N 2-chloro-4-propan-2-ylpyrimidine Chemical compound CC(C)C1=CC=NC(Cl)=N1 AOZNIFQUCUSYLD-UHFFFAOYSA-N 0.000 description 1
• FZZMTSNZRBFGGU-UHFFFAOYSA-N 2-chloro-7-fluoroquinazolin-4-amine Chemical compound FC1=CC=C2C(N)=NC(Cl)=NC2=C1 FZZMTSNZRBFGGU-UHFFFAOYSA-N 0.000 description 1
• PPLHKZYOCWZMPP-UHFFFAOYSA-N 2-isothiocyanato-4-(3-methoxyphenyl)pyrimidine Chemical compound COC1=CC=CC(C=2N=C(N=C=S)N=CC=2)=C1 PPLHKZYOCWZMPP-UHFFFAOYSA-N 0.000 description 1
• XIWFFWDVXJWCRA-UHFFFAOYSA-N 2-methoxy-6-pyrimidin-5-ylpyrimidin-4-amine Chemical compound COC1=NC(N)=CC(C=2C=NC=NC=2)=N1 XIWFFWDVXJWCRA-UHFFFAOYSA-N 0.000 description 1
• USBDVWRRXXQEOL-UHFFFAOYSA-N 2-pyridin-3-ylpyrimidin-4-amine Chemical compound NC1=CC=NC(C=2C=NC=CC=2)=N1 USBDVWRRXXQEOL-UHFFFAOYSA-N 0.000 description 1
• OCWBGKZFOYMCCN-UHFFFAOYSA-N 3,5-dichloropyridin-2-amine Chemical compound NC1=NC=C(Cl)C=C1Cl OCWBGKZFOYMCCN-UHFFFAOYSA-N 0.000 description 1
• LGXBEALMUUYEJV-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-2,2-diethoxypropanimidamide Chemical compound ClC=1C=C(CC(C(N)=N)(OCC)OCC)C=CC=1Cl LGXBEALMUUYEJV-UHFFFAOYSA-N 0.000 description 1
• VMSZFBSYWXMXRF-UHFFFAOYSA-N 3-isothiocyanatopyridine Chemical compound S=C=NC1=CC=CN=C1 VMSZFBSYWXMXRF-UHFFFAOYSA-N 0.000 description 1
• SMWAOXCEPHEGFV-UHFFFAOYSA-N 4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine Chemical compound C1CCCC2=C1N=C(N)S2 SMWAOXCEPHEGFV-UHFFFAOYSA-N 0.000 description 1
• CRRAQLWJVYODCL-UHFFFAOYSA-N 4,5-dichloropyridin-2-amine Chemical compound NC1=CC(Cl)=C(Cl)C=N1 CRRAQLWJVYODCL-UHFFFAOYSA-N 0.000 description 1
• WUTXFLYFZOMYSF-UHFFFAOYSA-N 4-(4-methoxyphenyl)-5-methyl-1,3-thiazol-2-amine Chemical compound C1=CC(OC)=CC=C1C1=C(C)SC(N)=N1 WUTXFLYFZOMYSF-UHFFFAOYSA-N 0.000 description 1
• OERIHGQAGTVWPN-UHFFFAOYSA-N 4-(difluoromethoxy)-2-fluorobenzonitrile Chemical compound FC(F)OC1=CC=C(C#N)C(F)=C1 OERIHGQAGTVWPN-UHFFFAOYSA-N 0.000 description 1
• NDEZTSHWEPQVBX-UHFFFAOYSA-N 4-(difluoromethoxy)aniline Chemical compound NC1=CC=C(OC(F)F)C=C1 NDEZTSHWEPQVBX-UHFFFAOYSA-N 0.000 description 1
• OEQQFQXMCPMEIH-UHFFFAOYSA-N 4-chloro-1,3-benzothiazol-2-amine Chemical compound C1=CC=C2SC(N)=NC2=C1Cl OEQQFQXMCPMEIH-UHFFFAOYSA-N 0.000 description 1
• RRMVDLLCVGZDMH-UHFFFAOYSA-N 4-chloro-5,6-dimethylpyrimidin-2-amine Chemical compound CC1=NC(N)=NC(Cl)=C1C RRMVDLLCVGZDMH-UHFFFAOYSA-N 0.000 description 1
• OPFFYLJLHPZSEO-UHFFFAOYSA-N 4-chlorofuro[3,2-c]pyridine Chemical compound ClC1=NC=CC2=C1C=CO2 OPFFYLJLHPZSEO-UHFFFAOYSA-N 0.000 description 1
• 229960000549 4-dimethylaminophenol Drugs 0.000 description 1
• GRIATXVEXOFBGO-UHFFFAOYSA-N 4-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=CC2=C1N=C(N)S2 GRIATXVEXOFBGO-UHFFFAOYSA-N 0.000 description 1
• SJISCEAZUHNOMD-UHFFFAOYSA-N 4-phenylcyclohexan-1-amine Chemical compound C1CC(N)CCC1C1=CC=CC=C1 SJISCEAZUHNOMD-UHFFFAOYSA-N 0.000 description 1
• LGPVXXJBWWYOSL-UHFFFAOYSA-N 4-propan-2-yl-1,3-thiazol-2-amine Chemical compound CC(C)C1=CSC(N)=N1 LGPVXXJBWWYOSL-UHFFFAOYSA-N 0.000 description 1
• MLNFMFAMNBGAQT-UHFFFAOYSA-N 4-propan-2-yloxyaniline Chemical compound CC(C)OC1=CC=C(N)C=C1 MLNFMFAMNBGAQT-UHFFFAOYSA-N 0.000 description 1
• LQHQKYWYKPLKCH-UHFFFAOYSA-N 4-pyridin-3-ylpyrimidin-2-amine Chemical compound NC1=NC=CC(C=2C=NC=CC=2)=N1 LQHQKYWYKPLKCH-UHFFFAOYSA-N 0.000 description 1
• PWRHKLKFADDKHS-UHFFFAOYSA-N 5,6-diamino-1h-pyrimidin-4-one Chemical compound NC=1NC=NC(=O)C=1N PWRHKLKFADDKHS-UHFFFAOYSA-N 0.000 description 1
• VKULPGMHEHWFFN-UHFFFAOYSA-N 5,7-dichloroisoquinolin-1-amine Chemical compound C1=C(Cl)C=C2C(N)=NC=CC2=C1Cl VKULPGMHEHWFFN-UHFFFAOYSA-N 0.000 description 1
• MVRGZAICFHFZIJ-UHFFFAOYSA-N 5-(4-methoxyphenyl)-1,3-thiazol-2-amine Chemical compound C1=CC(OC)=CC=C1C1=CN=C(N)S1 MVRGZAICFHFZIJ-UHFFFAOYSA-N 0.000 description 1
• LWYPLPIJTCQWCF-UHFFFAOYSA-N 5-(difluoromethoxy)-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound C1=C(OC(F)F)N=C2SC(N)=NC2=C1 LWYPLPIJTCQWCF-UHFFFAOYSA-N 0.000 description 1
• GSCRYWWEBZTTBF-UHFFFAOYSA-N 5-bromo-4-propan-2-ylpyrimidin-2-amine Chemical compound CC(C)C1=NC(N)=NC=C1Br GSCRYWWEBZTTBF-UHFFFAOYSA-N 0.000 description 1
• MDQXGHBCDCOOSM-UHFFFAOYSA-N 5-bromopyridin-3-amine Chemical compound NC1=CN=CC(Br)=C1 MDQXGHBCDCOOSM-UHFFFAOYSA-N 0.000 description 1
• DGRCJSWXMGENMG-UHFFFAOYSA-N 5-chloro-4-methylpyridin-2-amine Chemical compound CC1=CC(N)=NC=C1Cl DGRCJSWXMGENMG-UHFFFAOYSA-N 0.000 description 1
• WCCLUBJCLSIZOC-UHFFFAOYSA-N 5-chloro-[1,3]thiazolo[5,4-b]pyridin-2-amine Chemical compound C1=C(Cl)N=C2SC(N)=NC2=C1 WCCLUBJCLSIZOC-UHFFFAOYSA-N 0.000 description 1
• XGAKNUPZXKPFOS-UHFFFAOYSA-N 5-cyclopentyloxypyrimidin-2-amine Chemical compound C1=NC(N)=NC=C1OC1CCCC1 XGAKNUPZXKPFOS-UHFFFAOYSA-N 0.000 description 1
• XJKJHILCYUUVSJ-UHFFFAOYSA-N 5-methoxypyridin-2-amine Chemical compound COC1=CC=C(N)N=C1 XJKJHILCYUUVSJ-UHFFFAOYSA-N 0.000 description 1
• XKWSQIMYNVLGBO-UHFFFAOYSA-N 5-nitro-1h-pyridin-2-one Chemical compound OC1=CC=C([N+]([O-])=O)C=N1 XKWSQIMYNVLGBO-UHFFFAOYSA-N 0.000 description 1
• LSLUWQIENURREM-UHFFFAOYSA-N 5-phenyl-1,3-thiazol-2-amine Chemical compound S1C(N)=NC=C1C1=CC=CC=C1 LSLUWQIENURREM-UHFFFAOYSA-N 0.000 description 1
• LXRKXJMZWGBMOV-UHFFFAOYSA-N 6,7-dichloroisoquinolin-1-amine Chemical compound ClC1=C(Cl)C=C2C(N)=NC=CC2=C1 LXRKXJMZWGBMOV-UHFFFAOYSA-N 0.000 description 1
• JMRHKUHTNHRFON-UHFFFAOYSA-N 6,8-dichloroisoquinolin-3-amine Chemical compound ClC1=CC(Cl)=C2C=NC(N)=CC2=C1 JMRHKUHTNHRFON-UHFFFAOYSA-N 0.000 description 1
• AJWURYOLKGMWBS-UHFFFAOYSA-N 6-(2-methoxypyrimidin-5-yl)pyrimidin-4-amine Chemical compound C1=NC(OC)=NC=C1C1=CC(N)=NC=N1 AJWURYOLKGMWBS-UHFFFAOYSA-N 0.000 description 1
• HTWQXUINJKVXIO-UHFFFAOYSA-N 6-(4-chlorophenyl)pyrimidin-4-amine Chemical compound C1=NC(N)=CC(C=2C=CC(Cl)=CC=2)=N1 HTWQXUINJKVXIO-UHFFFAOYSA-N 0.000 description 1
• JHQJTIIYVDDSEN-UHFFFAOYSA-N 6-[tert-butyl(dimethyl)silyl]oxy-1,3-benzothiazol-2-amine Chemical compound CC(C)(C)[Si](C)(C)OC1=CC=C2N=C(N)SC2=C1 JHQJTIIYVDDSEN-UHFFFAOYSA-N 0.000 description 1
• ZFXMWBGQRGABCI-UHFFFAOYSA-N 6-amino-2,4-dimethylpyridine-3-carbonitrile Chemical compound CC1=CC(N)=NC(C)=C1C#N ZFXMWBGQRGABCI-UHFFFAOYSA-N 0.000 description 1
• OZAIJUZOQOBQDW-UHFFFAOYSA-N 6-amino-2-methylpyridine-3-carbonitrile Chemical compound CC1=NC(N)=CC=C1C#N OZAIJUZOQOBQDW-UHFFFAOYSA-N 0.000 description 1
• XYAFECHDSIQGHU-UHFFFAOYSA-N 6-bromo-[1,3]thiazolo[4,5-b]pyrazin-2-amine Chemical compound C1=C(Br)N=C2SC(N)=NC2=N1 XYAFECHDSIQGHU-UHFFFAOYSA-N 0.000 description 1
• PQKLBIXLXFRNKT-UHFFFAOYSA-N 6-bromoisoquinolin-3-amine Chemical compound BrC1=CC=C2C=NC(N)=CC2=C1 PQKLBIXLXFRNKT-UHFFFAOYSA-N 0.000 description 1
• VMNXKIDUTPOHPO-UHFFFAOYSA-N 6-chloro-1,3-benzothiazol-2-amine Chemical compound C1=C(Cl)C=C2SC(N)=NC2=C1 VMNXKIDUTPOHPO-UHFFFAOYSA-N 0.000 description 1
• KOYJWFGMEBETBU-UHFFFAOYSA-N 6-ethoxy-1,3-benzothiazol-2-amine Chemical compound CCOC1=CC=C2N=C(N)SC2=C1 KOYJWFGMEBETBU-UHFFFAOYSA-N 0.000 description 1
• KZHGPDSVHSDCMX-UHFFFAOYSA-N 6-methoxy-1,3-benzothiazol-2-amine Chemical compound COC1=CC=C2N=C(N)SC2=C1 KZHGPDSVHSDCMX-UHFFFAOYSA-N 0.000 description 1
• UUVDJIWRSIJEBS-UHFFFAOYSA-N 6-methoxypyridin-3-amine Chemical compound COC1=CC=C(N)C=N1 UUVDJIWRSIJEBS-UHFFFAOYSA-N 0.000 description 1
• DZWTXWPRWRLHIL-UHFFFAOYSA-N 6-methyl-1,3-benzothiazol-2-amine Chemical compound CC1=CC=C2N=C(N)SC2=C1 DZWTXWPRWRLHIL-UHFFFAOYSA-N 0.000 description 1
• CDCFXBSOKSIQPU-UHFFFAOYSA-N 6-phenylmethoxypyridin-3-amine Chemical compound N1=CC(N)=CC=C1OCC1=CC=CC=C1 CDCFXBSOKSIQPU-UHFFFAOYSA-N 0.000 description 1
• FBTKUAFGTDENLW-UHFFFAOYSA-N 7-bromoisoquinolin-3-amine Chemical compound C1=C(Br)C=C2C=NC(N)=CC2=C1 FBTKUAFGTDENLW-UHFFFAOYSA-N 0.000 description 1
• CUOUUOGXWPOSHD-UHFFFAOYSA-N 7-methoxy-5-methyl-[1,3]thiazolo[5,4-d]pyrimidin-2-amine Chemical compound COC1=NC(C)=NC2=C1N=C(N)S2 CUOUUOGXWPOSHD-UHFFFAOYSA-N 0.000 description 1
• QPKYPGWRTFUFOU-UHFFFAOYSA-N 7-methoxy-[1,3]thiazolo[5,4-d]pyrimidin-2-amine Chemical compound COC1=NC=NC2=C1N=C(N)S2 QPKYPGWRTFUFOU-UHFFFAOYSA-N 0.000 description 1
• 229930000680 A04AD01 - Scopolamine Natural products 0.000 description 1
• 208000007415 Anhedonia Diseases 0.000 description 1
• 229930003347 Atropine Natural products 0.000 description 1
• 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
• HAKDQONYWTWVGA-UHFFFAOYSA-N C1=C(N=C2C(=N1)SC(=N2)NC(=S)S)Br Chemical compound C1=C(N=C2C(=N1)SC(=N2)NC(=S)S)Br HAKDQONYWTWVGA-UHFFFAOYSA-N 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 108090000312 Calcium Channels Proteins 0.000 description 1
• 102000003922 Calcium Channels Human genes 0.000 description 1
• 239000004215 Carbon black (E152) Substances 0.000 description 1
• 108091005462 Cation channels Proteins 0.000 description 1
• VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
• 102000009660 Cholinergic Receptors Human genes 0.000 description 1
• 108010009685 Cholinergic Receptors Proteins 0.000 description 1
• KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
• 206010010144 Completed suicide Diseases 0.000 description 1
• 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
• KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 description 1
• 206010012239 Delusion Diseases 0.000 description 1
• 206010012289 Dementia Diseases 0.000 description 1
• FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
• 238000002965 ELISA Methods 0.000 description 1
• VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
• 239000007995 HEPES buffer Substances 0.000 description 1
• 229910004373 HOAc Inorganic materials 0.000 description 1
• 208000004547 Hallucinations Diseases 0.000 description 1
• 239000012981 Hank's balanced salt solution Substances 0.000 description 1
• 208000005176 Hepatitis C Diseases 0.000 description 1
• UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
• CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
• AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
• RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
• STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
• 206010061218 Inflammation Diseases 0.000 description 1
• 239000007836 KH2PO4 Substances 0.000 description 1
• JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
• 102000004086 Ligand-Gated Ion Channels Human genes 0.000 description 1
• 108090000543 Ligand-Gated Ion Channels Proteins 0.000 description 1
• WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
• 208000026139 Memory disease Diseases 0.000 description 1
• 241001465754 Metazoa Species 0.000 description 1
• AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
• STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
• FEYNFHSRETUBEM-UHFFFAOYSA-N N-[3-(1,1-difluoroethyl)phenyl]-1-(4-methoxyphenyl)-3-methyl-5-oxo-4H-pyrazole-4-carboxamide Chemical compound COc1ccc(cc1)N1N=C(C)C(C(=O)Nc2cccc(c2)C(C)(F)F)C1=O FEYNFHSRETUBEM-UHFFFAOYSA-N 0.000 description 1
• MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
• 229910017974 NH40H Inorganic materials 0.000 description 1
• 229910002651 NO3 Inorganic materials 0.000 description 1
• 102000004108 Neurotransmitter Receptors Human genes 0.000 description 1
• 108090000590 Neurotransmitter Receptors Proteins 0.000 description 1
• NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
• 240000007817 Olea europaea Species 0.000 description 1
• 229910019142 PO4 Inorganic materials 0.000 description 1
• 206010033864 Paranoia Diseases 0.000 description 1
• 208000027099 Paranoid disease Diseases 0.000 description 1
• NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 1
• 108010077495 Peptide oostatic hormone Proteins 0.000 description 1
• PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
• ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
• 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
• 102000007568 Proto-Oncogene Proteins c-fos Human genes 0.000 description 1
• 108010071563 Proto-Oncogene Proteins c-fos Proteins 0.000 description 1
• WTKZEGDFNFYCGP-UHFFFAOYSA-N Pyrazole Chemical compound C=1C=NNC=1 WTKZEGDFNFYCGP-UHFFFAOYSA-N 0.000 description 1
• 241000700157 Rattus norvegicus Species 0.000 description 1
• 206010041243 Social avoidant behaviour Diseases 0.000 description 1
• FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 1
• RHQDFWAXVIIEBN-UHFFFAOYSA-N Trifluoroethanol Chemical compound OCC(F)(F)F RHQDFWAXVIIEBN-UHFFFAOYSA-N 0.000 description 1
• HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
• YGCODSQDUUUKIV-UHFFFAOYSA-N Zoxazolamine Chemical compound ClC1=CC=C2OC(N)=NC2=C1 YGCODSQDUUUKIV-UHFFFAOYSA-N 0.000 description 1
• WFIHKLWVLPBMIQ-UHFFFAOYSA-N [1,3]thiazolo[5,4-b]pyridine Chemical compound C1=CN=C2SC=NC2=C1 WFIHKLWVLPBMIQ-UHFFFAOYSA-N 0.000 description 1
• XPOLVIIHTDKJRY-UHFFFAOYSA-N acetic acid;methanimidamide Chemical compound NC=N.CC(O)=O XPOLVIIHTDKJRY-UHFFFAOYSA-N 0.000 description 1
• CSCPPACGZOOCGX-WFGJKAKNSA-N acetone d6 Chemical compound [2H]C([2H])([2H])C(=O)C([2H])([2H])[2H] CSCPPACGZOOCGX-WFGJKAKNSA-N 0.000 description 1
• 230000002378 acidificating effect Effects 0.000 description 1
• 229950010850 acistrate Drugs 0.000 description 1
• 239000004480 active ingredient Substances 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• 150000001298 alcohols Chemical class 0.000 description 1
• 125000003342 alkenyl group Chemical group 0.000 description 1
• 125000003545 alkoxy group Chemical group 0.000 description 1
• 125000000304 alkynyl group Chemical group 0.000 description 1
• 229910052782 aluminium Inorganic materials 0.000 description 1
• XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
• 150000001408 amides Chemical class 0.000 description 1
• 125000003277 amino group Chemical group 0.000 description 1
• 229910021529 ammonia Inorganic materials 0.000 description 1
• 125000000129 anionic group Chemical group 0.000 description 1
• 230000000949 anxiolytic effect Effects 0.000 description 1
• 229910052786 argon Inorganic materials 0.000 description 1
• 150000004982 aromatic amines Chemical class 0.000 description 1
• 125000003118 aryl group Chemical group 0.000 description 1
• 239000012131 assay buffer Substances 0.000 description 1
• 125000004429 atom Chemical group 0.000 description 1
• RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
• 229960000396 atropine Drugs 0.000 description 1
• 239000003693 atypical antipsychotic agent Substances 0.000 description 1
• 229940127236 atypical antipsychotics Drugs 0.000 description 1
• XORXDJBDZJBCOC-UHFFFAOYSA-N azanium;acetonitrile;acetate Chemical compound [NH4+].CC#N.CC([O-])=O XORXDJBDZJBCOC-UHFFFAOYSA-N 0.000 description 1
• 230000006399 behavior Effects 0.000 description 1
• 230000003542 behavioural effect Effects 0.000 description 1
• JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
• SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
• 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
• MUALRAIOVNYAIW-UHFFFAOYSA-N binap Chemical compound C1=CC=CC=C1P(C=1C(=C2C=CC=CC2=CC=1)C=1C2=CC=CC=C2C=CC=1P(C=1C=CC=CC=1)C=1C=CC=CC=1)C1=CC=CC=C1 MUALRAIOVNYAIW-UHFFFAOYSA-N 0.000 description 1
• 239000011230 binding agent Substances 0.000 description 1
• 238000010170 biological method Methods 0.000 description 1
• JBIDUFGTLLGTBI-UHFFFAOYSA-N bis(methylsulfanyl)methanimine Chemical class CSC(=N)SC JBIDUFGTLLGTBI-UHFFFAOYSA-N 0.000 description 1
• 229910052797 bismuth Inorganic materials 0.000 description 1
• JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
• 230000037396 body weight Effects 0.000 description 1
• 210000005013 brain tissue Anatomy 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 230000009460 calcium influx Effects 0.000 description 1
• 239000002775 capsule Substances 0.000 description 1
• VNWKTOKETHGBQD-AKLPVKDBSA-N carbane Chemical compound [15CH4] VNWKTOKETHGBQD-AKLPVKDBSA-N 0.000 description 1
• 239000000969 carrier Substances 0.000 description 1
• 239000003054 catalyst Substances 0.000 description 1
• 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
• 125000002091 cationic group Chemical group 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000008859 change Effects 0.000 description 1
• DGLFSNZWRYADFC-UHFFFAOYSA-N chembl2334586 Chemical compound C1CCC2=CN=C(N)N=C2C2=C1NC1=CC=C(C#CC(C)(O)C)C=C12 DGLFSNZWRYADFC-UHFFFAOYSA-N 0.000 description 1
• 150000001805 chlorine compounds Chemical class 0.000 description 1
• NDTCXABJQNJPCF-UHFFFAOYSA-N chlorocyclopentane Chemical compound ClC1CCCC1 NDTCXABJQNJPCF-UHFFFAOYSA-N 0.000 description 1
• 239000002036 chloroform fraction Substances 0.000 description 1
• SKCNIGRBPJIUBQ-UHFFFAOYSA-N chloroform;ethyl acetate Chemical compound ClC(Cl)Cl.CCOC(C)=O SKCNIGRBPJIUBQ-UHFFFAOYSA-N 0.000 description 1
• OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
• 229960001231 choline Drugs 0.000 description 1
• 230000007278 cognition impairment Effects 0.000 description 1
• 231100000876 cognitive deterioration Toxicity 0.000 description 1
• 239000012230 colorless oil Substances 0.000 description 1
• 239000000470 constituent Substances 0.000 description 1
• 238000001816 cooling Methods 0.000 description 1
• LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 1
• 239000006071 cream Substances 0.000 description 1
• 238000011461 current therapy Methods 0.000 description 1
• ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
• XCIXKGXIYUWCLL-UHFFFAOYSA-N cyclopentanol Chemical compound OC1CCCC1 XCIXKGXIYUWCLL-UHFFFAOYSA-N 0.000 description 1
• 210000000805 cytoplasm Anatomy 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 230000003247 decreasing effect Effects 0.000 description 1
• 231100000868 delusion Toxicity 0.000 description 1
• 239000007933 dermal patch Substances 0.000 description 1
• 238000001514 detection method Methods 0.000 description 1
• 230000006866 deterioration Effects 0.000 description 1
• 238000011161 development Methods 0.000 description 1
• 238000003745 diagnosis Methods 0.000 description 1
• WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 1
• ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
• 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
• SXZIXHOMFPUIRK-UHFFFAOYSA-N diphenylmethanimine Chemical compound C=1C=CC=CC=1C(=N)C1=CC=CC=C1 SXZIXHOMFPUIRK-UHFFFAOYSA-N 0.000 description 1
• 229960003638 dopamine Drugs 0.000 description 1
• 230000003291 dopaminomimetic effect Effects 0.000 description 1
• 238000007876 drug discovery Methods 0.000 description 1
• 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 1
• 239000002024 ethyl acetate extract Substances 0.000 description 1
• DBPFRRFGLYGEJI-UHFFFAOYSA-N ethyl glyoxylate Chemical compound CCOC(=O)C=O DBPFRRFGLYGEJI-UHFFFAOYSA-N 0.000 description 1
• MXDFPKDNQYNZPK-UHFFFAOYSA-N ethyl n-(5-chloro-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)carbamate Chemical compound N1=C(Cl)N=C2SC(NC(=O)OCC)=NC2=C1 MXDFPKDNQYNZPK-UHFFFAOYSA-N 0.000 description 1
• BDTDECDAHYOJRO-UHFFFAOYSA-N ethyl n-(sulfanylidenemethylidene)carbamate Chemical compound CCOC(=O)N=C=S BDTDECDAHYOJRO-UHFFFAOYSA-N 0.000 description 1
• 238000011156 evaluation Methods 0.000 description 1
• 238000001704 evaporation Methods 0.000 description 1
• 230000008020 evaporation Effects 0.000 description 1
• 239000012091 fetal bovine serum Substances 0.000 description 1
• 239000012467 final product Substances 0.000 description 1
• 238000002073 fluorescence micrograph Methods 0.000 description 1
• 239000003269 fluorescent indicator Substances 0.000 description 1
• 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
• 239000006260 foam Substances 0.000 description 1
• 238000009472 formulation Methods 0.000 description 1
• 125000002541 furyl group Chemical group 0.000 description 1
• 239000001963 growth medium Substances 0.000 description 1
• 125000004438 haloalkoxy group Chemical group 0.000 description 1
• 125000001188 haloalkyl group Chemical group 0.000 description 1
• 125000005059 halophenyl group Chemical group 0.000 description 1
• 238000010438 heat treatment Methods 0.000 description 1
• 125000005842 heteroatom Chemical group 0.000 description 1
• 238000004896 high resolution mass spectrometry Methods 0.000 description 1
• 229930195733 hydrocarbon Natural products 0.000 description 1
• 238000003384 imaging method Methods 0.000 description 1
• 208000019014 inability to feed Diseases 0.000 description 1
• QNLOWBMKUIXCOW-UHFFFAOYSA-N indol-2-one Chemical compound C1=CC=CC2=NC(=O)C=C21 QNLOWBMKUIXCOW-UHFFFAOYSA-N 0.000 description 1
• PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
• RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
• 239000012442 inert solvent Substances 0.000 description 1
• 230000004054 inflammatory process Effects 0.000 description 1
• 230000005764 inhibitory process Effects 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
• VYCKDIRCVDCQAE-UHFFFAOYSA-N isoquinolin-3-amine Chemical compound C1=CC=C2C=NC(N)=CC2=C1 VYCKDIRCVDCQAE-UHFFFAOYSA-N 0.000 description 1
• CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
• 238000011813 knockout mouse model Methods 0.000 description 1
• 150000002611 lead compounds Chemical class 0.000 description 1
• 230000002197 limbic effect Effects 0.000 description 1
• 230000000670 limiting effect Effects 0.000 description 1
• 239000006194 liquid suspension Substances 0.000 description 1
• 229910052744 lithium Inorganic materials 0.000 description 1
• 239000012280 lithium aluminium hydride Substances 0.000 description 1
• 239000012139 lysis buffer Substances 0.000 description 1
• VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
• 210000004962 mammalian cell Anatomy 0.000 description 1
• 238000010907 mechanical stirring Methods 0.000 description 1
• 230000010534 mechanism of action Effects 0.000 description 1
• 239000002609 medium Substances 0.000 description 1
• 229960003194 meglumine Drugs 0.000 description 1
• 238000002844 melting Methods 0.000 description 1
• 230000008018 melting Effects 0.000 description 1
• 230000006386 memory function Effects 0.000 description 1
• 230000003340 mental effect Effects 0.000 description 1
• GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
• QGBPKJFJAVDUNC-UHFFFAOYSA-N methyl 4-methoxy-3-oxobutanoate Chemical compound COCC(=O)CC(=O)OC QGBPKJFJAVDUNC-UHFFFAOYSA-N 0.000 description 1
• 230000004048 modification Effects 0.000 description 1
• 238000012986 modification Methods 0.000 description 1
• HDZGCSFEDULWCS-UHFFFAOYSA-N monomethylhydrazine Chemical compound CNN HDZGCSFEDULWCS-UHFFFAOYSA-N 0.000 description 1
• 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
• 235000019796 monopotassium phosphate Nutrition 0.000 description 1
• MWGISGHYSNLOIO-UHFFFAOYSA-N n'-[(3,4-dichlorophenyl)methyl]-2,2-diethoxyethanimidamide Chemical compound CCOC(OCC)C(=N)NCC1=CC=C(Cl)C(Cl)=C1 MWGISGHYSNLOIO-UHFFFAOYSA-N 0.000 description 1
• SHTZWMUGTLYWKT-UHFFFAOYSA-N n'-[(3-bromophenyl)methyl]-2,2-diethoxyethanimidamide Chemical compound CCOC(OCC)C(=N)NCC1=CC=CC(Br)=C1 SHTZWMUGTLYWKT-UHFFFAOYSA-N 0.000 description 1
• INXMNHNLPLWABV-UHFFFAOYSA-N n'-[(4-bromophenyl)methyl]-2,2-diethoxyethanimidamide Chemical compound CCOC(OCC)C(=N)NCC1=CC=C(Br)C=C1 INXMNHNLPLWABV-UHFFFAOYSA-N 0.000 description 1
• VUSUESCSIUWQMT-UHFFFAOYSA-N n-(1,3-benzothiazol-2-yl)spiro[1-azabicyclo[2.2.2]octane-3,5'-4h-1,3-oxazole]-2'-amine Chemical compound C1N(CC2)CCC2C21OC(NC=1SC3=CC=CC=C3N=1)=NC2 VUSUESCSIUWQMT-UHFFFAOYSA-N 0.000 description 1
• BRSUAKMKDAAYJX-UHFFFAOYSA-N n-(2-amino-1,3-benzothiazol-6-yl)acetamide Chemical compound CC(=O)NC1=CC=C2N=C(N)SC2=C1 BRSUAKMKDAAYJX-UHFFFAOYSA-N 0.000 description 1
• YPYBXVUXWWJIND-UHFFFAOYSA-N n-(4-chloro-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C=2C(Cl)=CC=CC=2SC=1NC(=S)N1C=CN=C1 YPYBXVUXWWJIND-UHFFFAOYSA-N 0.000 description 1
• FMASTMURQSHELY-UHFFFAOYSA-N n-(4-fluoro-2-methylphenyl)-3-methyl-n-[(2-methyl-1h-indol-4-yl)methyl]pyridine-4-carboxamide Chemical compound C1=CC=C2NC(C)=CC2=C1CN(C=1C(=CC(F)=CC=1)C)C(=O)C1=CC=NC=C1C FMASTMURQSHELY-UHFFFAOYSA-N 0.000 description 1
• NOALOJGCCOIRFR-UHFFFAOYSA-N n-(4-methyl-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound N=1C=2C(C)=CC=CC=2SC=1NC(=S)N1C=CN=C1 NOALOJGCCOIRFR-UHFFFAOYSA-N 0.000 description 1
• FUCCVTKQLLOEPO-UHFFFAOYSA-N n-(5-methoxy-[1,3]thiazolo[5,4-b]pyridin-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=NC(OC)=CC=C2N=C1NC(=S)N1C=CN=C1 FUCCVTKQLLOEPO-UHFFFAOYSA-N 0.000 description 1
• WDINSPOQKMZCHQ-UHFFFAOYSA-N n-(5-phenyl-1,3-thiazol-2-yl)imidazole-1-carbothioamide Chemical compound C1=CN=CN1C(=S)NC(S1)=NC=C1C1=CC=CC=C1 WDINSPOQKMZCHQ-UHFFFAOYSA-N 0.000 description 1
• URWMDWYEUVQFRS-UHFFFAOYSA-N n-(6-bromo-[1,3]thiazolo[4,5-b]pyrazin-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound C1=C(Br)N=C2SC(N=C(SC)SC)=NC2=N1 URWMDWYEUVQFRS-UHFFFAOYSA-N 0.000 description 1
• VWTRVYZJIAPBHR-UHFFFAOYSA-N n-(6-chloro-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(Cl)=CC=C2N=C1NC(=S)N1C=CN=C1 VWTRVYZJIAPBHR-UHFFFAOYSA-N 0.000 description 1
• YPWKLBCTOUEZKE-UHFFFAOYSA-N n-(6-chloropyridin-2-yl)-2,2-dimethylpropanamide Chemical compound CC(C)(C)C(=O)NC1=CC=CC(Cl)=N1 YPWKLBCTOUEZKE-UHFFFAOYSA-N 0.000 description 1
• RYFJHYNEJKFKIE-UHFFFAOYSA-N n-(6-ethoxy-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(OCC)=CC=C2N=C1NC(=S)N1C=CN=C1 RYFJHYNEJKFKIE-UHFFFAOYSA-N 0.000 description 1
• FQXJYXQXFVMXOQ-UHFFFAOYSA-N n-(6-methoxy-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(OC)=CC=C2N=C1NC(=S)N1C=CN=C1 FQXJYXQXFVMXOQ-UHFFFAOYSA-N 0.000 description 1
• AJVYWPXCDQCOEU-UHFFFAOYSA-N n-(6-methyl-1,3-benzothiazol-2-yl)imidazole-1-carbothioamide Chemical compound S1C2=CC(C)=CC=C2N=C1NC(=S)N1C=CN=C1 AJVYWPXCDQCOEU-UHFFFAOYSA-N 0.000 description 1
• HUBRSUQLBOOYKF-UHFFFAOYSA-N n-(7-methoxy-[1,3]thiazolo[5,4-d]pyrimidin-2-yl)-1,1-bis(methylsulfanyl)methanimine Chemical compound COC1=NC=NC2=C1N=C(N=C(SC)SC)S2 HUBRSUQLBOOYKF-UHFFFAOYSA-N 0.000 description 1
• YJZQFLXZZGZDKK-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-6-methoxyquinoxalin-2-amine Chemical compound COC1=CC(OC)=CC=C1CNC1=CN=C(C=C(OC)C=C2)C2=N1 YJZQFLXZZGZDKK-UHFFFAOYSA-N 0.000 description 1
• NTKLQWVHHBNEPH-UHFFFAOYSA-N n-[(2,4-dimethoxyphenyl)methyl]-7-methoxyquinoxalin-2-amine Chemical compound COC1=CC(OC)=CC=C1CNC1=CN=C(C=CC(OC)=C2)C2=N1 NTKLQWVHHBNEPH-UHFFFAOYSA-N 0.000 description 1
• FBMCKFANBCCIFK-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]imidazole-1-carbothioamide Chemical compound C1=CC(OC)=CC=C1C1=CSC(NC(=S)N2C=NC=C2)=N1 FBMCKFANBCCIFK-UHFFFAOYSA-N 0.000 description 1
• OESGJWFGVHFAAE-UHFFFAOYSA-N n-[4-(4-methoxyphenyl)-5-methyl-1,3-thiazol-2-yl]imidazole-1-carboxamide Chemical compound C1=CC(OC)=CC=C1C1=C(C)SC(NC(=O)N2C=NC=C2)=N1 OESGJWFGVHFAAE-UHFFFAOYSA-N 0.000 description 1
• NNKPHNTWNILINE-UHFFFAOYSA-N n-cyclopropyl-3-fluoro-4-methyl-5-[3-[[1-[2-[2-(methylamino)ethoxy]phenyl]cyclopropyl]amino]-2-oxopyrazin-1-yl]benzamide Chemical compound CNCCOC1=CC=CC=C1C1(NC=2C(N(C=3C(=C(F)C=C(C=3)C(=O)NC3CC3)C)C=CN=2)=O)CC1 NNKPHNTWNILINE-UHFFFAOYSA-N 0.000 description 1
• 229930014626 natural product Natural products 0.000 description 1
• 210000002569 neuron Anatomy 0.000 description 1
• 230000007996 neuronal plasticity Effects 0.000 description 1
• 229920002113 octoxynol Polymers 0.000 description 1
• 229910052763 palladium Inorganic materials 0.000 description 1
• 230000036961 partial effect Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 230000007310 pathophysiology Effects 0.000 description 1
• 235000019371 penicillin G benzathine Nutrition 0.000 description 1
• 210000001428 peripheral nervous system Anatomy 0.000 description 1
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
• 239000010452 phosphate Substances 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 229960005235 piperonyl butoxide Drugs 0.000 description 1
• LZMJNVRJMFMYQS-UHFFFAOYSA-N poseltinib Chemical compound C1CN(C)CCN1C(C=C1)=CC=C1NC1=NC(OC=2C=C(NC(=O)C=C)C=CC=2)=C(OC=C2)C2=N1 LZMJNVRJMFMYQS-UHFFFAOYSA-N 0.000 description 1
• 230000008092 positive effect Effects 0.000 description 1
• 239000011591 potassium Substances 0.000 description 1
• 229910052700 potassium Inorganic materials 0.000 description 1
• NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
• GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
• 230000001376 precipitating effect Effects 0.000 description 1
• DBABZHXKTCFAPX-UHFFFAOYSA-N probenecid Chemical compound CCCN(CCC)S(=O)(=O)C1=CC=C(C(O)=O)C=C1 DBABZHXKTCFAPX-UHFFFAOYSA-N 0.000 description 1
• 229960003081 probenecid Drugs 0.000 description 1
• 238000012545 processing Methods 0.000 description 1
• 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
• 208000020016 psychiatric disease Diseases 0.000 description 1
• 239000012264 purified product Substances 0.000 description 1
• PBMFSQRYOILNGV-UHFFFAOYSA-N pyridazine Chemical compound C1=CC=NN=C1 PBMFSQRYOILNGV-UHFFFAOYSA-N 0.000 description 1
• NWELCUKYUCBVKK-UHFFFAOYSA-N pyridin-2-ylhydrazine Chemical compound NNC1=CC=CC=N1 NWELCUKYUCBVKK-UHFFFAOYSA-N 0.000 description 1
• QLULGIRFKAWHOJ-UHFFFAOYSA-N pyridin-4-ylboronic acid Chemical compound OB(O)C1=CC=NC=C1 QLULGIRFKAWHOJ-UHFFFAOYSA-N 0.000 description 1
• UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
• LJXQPZWIHJMPQQ-UHFFFAOYSA-N pyrimidin-2-amine Chemical compound NC1=NC=CC=N1 LJXQPZWIHJMPQQ-UHFFFAOYSA-N 0.000 description 1
• OYRRZWATULMEPF-UHFFFAOYSA-N pyrimidin-4-amine Chemical compound NC1=CC=NC=N1 OYRRZWATULMEPF-UHFFFAOYSA-N 0.000 description 1
• 239000012047 saturated solution Substances 0.000 description 1
• STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
• 229960002646 scopolamine Drugs 0.000 description 1
• 238000007391 self-medication Methods 0.000 description 1
• 230000009151 sensory gating Effects 0.000 description 1
• 238000000926 separation method Methods 0.000 description 1
• 230000000391 smoking effect Effects 0.000 description 1
• RMBAVIFYHOYIFM-UHFFFAOYSA-M sodium methanethiolate Chemical compound [Na+].[S-]C RMBAVIFYHOYIFM-UHFFFAOYSA-M 0.000 description 1
• MRTAVLDNYYEJHK-UHFFFAOYSA-M sodium;2-chloro-2,2-difluoroacetate Chemical compound [Na+].[O-]C(=O)C(F)(F)Cl MRTAVLDNYYEJHK-UHFFFAOYSA-M 0.000 description 1
• 239000011343 solid material Substances 0.000 description 1
• 239000008247 solid mixture Substances 0.000 description 1
• 241000894007 species Species 0.000 description 1
• 230000002739 subcortical effect Effects 0.000 description 1
• KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
• 230000015883 synaptic transmission, dopaminergic Effects 0.000 description 1
• 238000010189 synthetic method Methods 0.000 description 1
• 239000006188 syrup Substances 0.000 description 1
• 235000020357 syrup Nutrition 0.000 description 1
• 229940095064 tartrate Drugs 0.000 description 1
• CZDYPVPMEAXLPK-UHFFFAOYSA-N tetramethylsilane Chemical compound C[Si](C)(C)C CZDYPVPMEAXLPK-UHFFFAOYSA-N 0.000 description 1
• VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
• ZWZVWGITAAIFPS-UHFFFAOYSA-N thiophosgene Chemical compound ClC(Cl)=S ZWZVWGITAAIFPS-UHFFFAOYSA-N 0.000 description 1
• JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
• 231100000419 toxicity Toxicity 0.000 description 1
• 230000001988 toxicity Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000000844 transformation Methods 0.000 description 1
• UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
• 229960000281 trometamol Drugs 0.000 description 1
• 238000003828 vacuum filtration Methods 0.000 description 1
• 210000001186 vagus nerve Anatomy 0.000 description 1
• 239000003039 volatile agent Substances 0.000 description 1
• 239000011534 wash buffer Substances 0.000 description 1
• 239000000080 wetting agent Substances 0.000 description 1
• 230000003936 working memory Effects 0.000 description 1
• 239000011701 zinc Substances 0.000 description 1
• 229910052725 zinc Inorganic materials 0.000 description 1